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Abstract: Existing studies have documented the adverse impacts of PTSD both in military
service members as well as their families. The impacts of PTSD on physical health were
only observed among the service members and veterans. There are major gaps in the field
including in the understanding of mechanism that connects PTSD and physical health
consequences, as well as evidence of spillover impacts of PTSD on physical health within
the family of service members.The current study addresses this gap through investigation
on the role of physiological functions including physiological responses (e.g., blood
pressure), pre-disease biomarkers (e.g., inflammation), and evaluating risk for and the
impacts of PTSD. The current study also proposed a mechanism to understand the
connection between PTSD and pathology through those variables. Further, comparisons
of the proposed model across different sociodemographic groups were also conducted. A
secondary data analysis from CERNER Health Facts, specifically using path and multiple
group path analyses, was utilized to attain the goal of the study. Findings yielded that
physiological profiles, including pulse rate and leukocyte count, can provide insight into
the risk of PTSD. Following PTSD diagnosis, alterations in pulse rate and N/L ratio were
observed, confirming that PTSD altered different physiological functions. PTSD was also
directly connected to pathology. Further, these physiological responses following PTSD
were found to be connected and provided insights on the mechanisms of the connection
between PTSD and pathology. However, comparisons of proposed model across different
sociodemographic groups indicated that the proposed model needs to be used with
caution as it did not capture the mechanisms equally across different groups.
Nevertheless, it provides insights into the unexplored area. The findings from this study
contributed to important movement for the integration between mental and physical
health services especially in PTSD treatments. Monitoring of physiological markers of
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Post-traumatic Stress Disorder (PTSD) is a debilitating mental health problem.
Individuals with PTSD often repeatedly re-live their traumatic memories, which is a core
feature of PTSD. These repeated flashbacks of intrusive and unwanted memories have
been reported to disrupt relationships, increase mortality and morbidity, and derange
mental health (Allen et al., 2018; Nichter et al., 2019; Britvic et al., 2015; Schlenger et al.,
2015).
The current study will focus on the relationship between PTSD and physical
health. Studies report PTSD enhances the risk of diseases such as cardiovascular disease
and sleep-related disorders (Beristianos et al, 2016; Violanti et al., 2006; Boscarino, 2008;
Williams et al., 2015; El-Gabalawy et al., 2018; Krakow et al., 2001). The potential
connection between PTSD and pathology raises concern as it could increase disability,
lower quality of life, and impact distinct functions of those with PTSD. Unfortunately,
the mechanism that connects the two are not fully understood. For this reason, there are
numerous challenges facing prevention and intervention. Nevertheless, existing studies
provide evidence of physiological alterations that could offer insights into the
mechanisms underlying associations between PTSD and pathology. A set of studies
documented alterations in blood pressure, pulse rate, and inflammation following PTSD
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(Buckley et al., 2004; Lindqvist et al., 2014). On the contrary, other studies have
found that certain physiological response characteristics (e.g.,blood pressure) predict the
development of PTSD. Heart rate was also reported to be predictive of later development
of PTSD (Morris et al., 2016; Bryant et al., 2011). This evidence raises the question of
temporal precedence in the relationship between physiological markers and PTSD, and
there is no study to date with extensive data to delineate the effect. The allostatic load
model proposed a systemic adaptation mechanism that can be applied to understand the
connection between PTSD and pathology. The mechanism ranges from adaptive to
maladaptive that could gradually become detrimental to the system. Further, the current
study will evaluate bi-directional relationships between PTSD and physiological markers.
PTSD is a growing concern in the military population. An estimated 5-15% of
active service members received a clinical diagnosis of PTSD during or after completing
their military assignment in the past decade (Ramchand et al., 2008). The estimated
prevalence of PTSD in the military population is higher than in the general population
(APA, 2013). Studies also report increased morbidity among service members with
PTSD (Beristianos et al., 2016). These studies illustrate the prevalence of PTSD and
associations with poorer physical health among this population.
Further evidence points to another detrimental impact of PTSD beyond service
members. Previous studies indicate a higher risk of marital problems and mental health
issues for the spouse and children of military service members (Dirkzwager et al., 2005;
Lester et al., 2010). It is worth noting that physical health risks for this population
havenot been examined yet. However, deriving from existing evidence, this population
may also be at an increased risk for physical health problems. To evaluate physical health
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impacts on military family members, Figley’s work (1995) on compassion fatigue offered
early evidence of a contemporary approach of systemic impact on psychological trauma.
Evidence showed that secondary trauma can be acquired from interaction with
traumatized individuals (Boscarino, et al., 2010). This perspective can advance our
understanding of the detrimental effect of PTSD beyond the traumatized individuals.
The current study has three major aims. First, the current study will evaluate
whether physiological markers predict PTSD. Secondly, the impacts of PTSD on
physiological marker alteration following a PTSD diagnosis will be examined. Finally,
the relationship between PTSD and pathology will be evaluated through physiological
markers. To accomplish this, a secondary dataset, Cerner Health Facts® was obtained
from the Center for Health System Innovation (CHSI) at Oklahoma State University.
Cerner Health Facts® is a HIPAA compliant electronic health record (EHR) that ICD
diagnosis codes for mental and physical health and physiological markers
collectedthrough examination and laboratory tests, as well as several sociodemographic
factors.
The current study will fill several gaps within the field. Existing studies have been
limited to PTSD impacts on service members (Beristianos et al., 2016; O’Donovan et al.,
2015; Yaffe et al., 2010). This study will extend the knowledge on the impact of PTSD
on physical health to include family members of service men and women. Second, the
current study will be used to test a mechanistic model to better understand underlying
mechanisms of PTSD and physical health. Furthermore, findings from this study have the
potential to extend and improve theoretical insight regarding complexities in the PTSD-
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physical health association. It could also be utilized to inform and design prevention and
intervention programs to serve service members and their families.
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CHAPTER II
REVIEW OF THE LITERATURE
Problem Statement
Studies on the impacts of PTSD have been done quite extensively. Yet, there are
two major existing gaps in the study of PTSD. First, the underlying mechanisms between
PTSD and physical health are not well understood. However, there is some initial
evidence of physiological marker alterations relevant to PTSD (Buckley et al., 2004;
Muraoka et al., 1998; Vieweg et al., 2006) and inflammation (Lindqvist et al., 2017;
Kagan et al., 1999). Another set of evidence also notes strong associations between PTSD
and pathology development (CVD, Ahmadi et al., 2011; Sleep, El-Gabalawy et al., 2018).
This initial evidence on some variables that are potentially involved in the process will be
further reviewed. The integration and evaluation of a model that includes these variables
may offer explanation to the connection of PTSD and physical health. Secondly, there is
accumulated evidence on the functional and mental health impact, but not physical health
of family members of those with PTSD (Allen et al., 2018; Dirkzwager et al., 2005;
Herzog et al., 2011; Lester et al., 2010). Exploring the impact of transmission to family
members is an important step to advance understanding of PTSD impact and initiate
protection programs to minimize the impacts. The proposed study will fill these
previously identified gaps.
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Conceptualizing and Diagnosing Trauma
Existing literature includes different definitions and conceptualizations of
psychological trauma. Two major guidelines exist for psychological trauma; the
Diagnostic and Statistic Manual of Mental Disorder 5th Edition (DSM-5) published by
American Psychiatric Association (APA) and the International Classification of Disease
10 Clinical Modification (ICD-10-CM) issued by the World Health Organization (WHO).
Further details of each will be discussed.
According to the DSM-5, psychological trauma is defined as an exposure to
actual or threatened death, injury, or actual or sexual violence (APA, 2013). These
adverse experiences can be experienced directly or indirectly (APA, 2013). One could
witness traumatic events indirectly through learning about a relative’s or close friend’s
experience. Additionally, certain professions, such as first responders, may have elevated
risk of being exposed to trauma. To meet DSM-5 criteria for PTSD diagnosis requires the
symptoms of intrusion, avoidance, alteration in cognition and mood, and emotional
arousal and reactivity (APA, 2013). These symptoms must be present for longer than one
month.
Intrusion symptoms include involuntary and distressing memories and dreams,
dissociative reactions as if the traumatic event were re-occurring, psychological distress
toward reminders relevant to the traumatic event(s), and/or physiological reactions to
cues related to the traumatic event(s) (APA, 2013). Whereas an avoidance symptom may
include avoiding memory recall or reminders relevant to the traumatic event (APA, 2013).
Further, negative alteration symptoms in cognition and mood can vary relative to an
inability to remember the event, persistent and exaggerated negative beliefs about oneself,
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distorted beliefs about the cause of the event, prolonged negative emotional state, low
interest in significant activities, or detachment from others and absence of positive
emotion (APA, 2013). Finally, symptoms indicative of an alteration in arousal and
reactivity includes irritability and outburst, risk-taking behaviors, hypervigilance and
exaggerated startle response, problems with concentration, and sleep disturbance (APA,
2013).
On the other hand, the International Codebook for Diseases (ICD-10) defined
psychological trauma as any stressful, threatening, or catastrophic circumstance that can
precipitate distress in most people (WHO, 2019). Some symptoms listed for PTSD
include intrusive memories, alteration in emotion that affect self and relationship with
others, and alteration in arousal. One may relive their trauma through intrusive memories
and nightmares (WHO, 2019). Thus, it is common for individuals to avoid trauma-related
triggers. Further, the alteration in emotion, such as numbness, could lower interest in
things they previously enjoyed (anhedonia), decrease in responsiveness to the
environment, and detachment to existing relationships. Finally, alteration in arousal could
be manifested in sleep disturbances.
Theoretical and Conceptual Frameworks
Systemic Impact of PTSD
The work of Charles Figley (1997) offered a new lens to view PTSD. Figley
highlighted the impact of World War II on veterans’ family reintegration process (Figley,
1997). This historical event had significantly disturbed family life with the exit and return
of the service members. Many experienced psychological trauma-related symptoms from
a significant event that occurred during their service. It was found that the presence of
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trauma symptoms then could affect family function and dynamics. Through this
mechanism, the impact of individual psychological trauma could be transmitted to the
family.
Figley (date) also found that the transmission of psychological trauma extended
beyond family. Mental health professionals who provided services for impacted
individuals in the World Trade Center disaster reported significant trauma symptoms
(Boscarino et al., 2004; Boscarino, Adams & Figley, 2010). Figley and his colleagues’
work indicated that psychological trauma is a dynamic concept that can affect others
through interaction.
Despite the evidence of trauma transmission, most studies have evaluated PTSD
impacts at an individual level, especially in the physical health domain (Ahmadi et al.,
2011; O’Donovan et al., 2015). Thus, there is little understanding of the physical health
impact on the significant others of those who experienced traumatic events. While
isolating other aspects can offer clarity and potentially establish causality for the study, it
is important to acknowledge that individuals do not live in a vacuum. Thus, evaluating
the impacts of PTSD beyond those who experience it first-hand is an important step to
advancing the field and to extending protection and intervention services for those who
are impacted.
Allostatic Load Model
PTSD has been linked to altered physiological functioning as well as comorbidity
with various health conditions. Therefore, an integrative model is needed to understand
the mechanism that connects mental and physical health in the context of PTSD.
McEwen and Stellar (1993) introduced a theoretical perspective called the allostatic load
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model, which involves a balancing process to meet environmental demands through
alterations to maintain the stability of the system. One key assumption of this model is
that living organisms are able to regulate and maintain stability of their physiological
system, otherwise known as homeostasis (McEwen & Wingfield, 2003).
In the context of the human body, homeostasis is best represented by various
regulatory biological indicators including how acidic or basic a system is (pH measure)
and body temperature (McEwen & Wingfield, 2003). When a threat presents to the
system, the organism attempts to maintain homeostasis by making alterations to the body,
referred to as allostasis.
These alterations can create a temporary balance which could be critical for
organism survival. Yet, in the long-term, it could cause wear and tear to the body, and
this is known as allostatic load (McEwen & Stellar, 1993). Further, if allostatic load
persists or accumulates, it can develop into permanent damage to the system, referred to
as allostatic overload (McEwen & Stellar, 1993). One study documented evidence of
prolonged allostatic alteration load to health problems relevant to the cardiovascular and
metabolic systems (Dowd et al., 2009). Allostatic load model is a key determinant to
understanding illness and disease (McEwen & Wingfield, 2003).
Military Service and PTSD
The rate of Post-Traumatic Stress Disorder (PTSD) diagnoses among returned
military service members is estimated between 5-15% (Ramchand et al., 2008). The
number reported is higher than PTSD prevalence in the general U.S. population, which is
3.5% (APA, 2013). One potential explanation for the differences in prevalence is the
nature of the job in that military service members have enhanced risk of exposure to
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traumatic situations. During their service, military personnel may receive assignments to
serve in a high conflict region where they may encounter various threatening attacks.
Therefore, it is possible for military service members to be involved in witnessing or
experiencing injuries or threats to safety, both to themselves and others. Of those military
personnel who were deployed to Iraq and Afghanistan, 49% witnessed a friend be
wounded or killed, and 45% witnessed someone other than a friend be injured or killed
(Schell & Marshall, 2008).
The underlying connection between traumatic events exposure and the
psychopathological development of PTSD is not well understood. However, recent work
on the concept of moral injury may be able to explain this connection in the context of
military PTSD. Moral injury refers to the concept of violations of moral value that one
has (Nash & Litz, 2013). Military service members must follow the orders made by their
superior despite their personal values. Hence, the service members are especially at
higher risk to develop PTSD if the orders they received contradict their values.
Additionally, various stories and interactions have also been documented to serve as a
potential mechanism of moral injury to family members (Nash & Litz, 2013). This
evidence offers potential insight to the enhanced risk of developing PTSD for military
service members and their families.
Existing literature has established detrimental effects of PTSD on military service
men and women. In regard to emotion reactivity, military personnel diagnosed with
PTSD commonly have higher rates of anger reactivity when presented with trauma-
related stimuli compared to those without PTSD diagnosis (Taft et al., 2007). Without
proper intervention, these continuous negative emotions experienced by service members
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may be an overwhelming experience that can later develop to be dysfunctional behavior
including addiction, alcohol abuse (Frazier & Burnett, 1994), and aggressive behaviors
(e.g., destroy property, threat) (Jakupcak et al., 2007).
Unfortunately, research has also documented evidence of a spillover effect of
PTSD onto the significant others of service members. As service members with PTSD
have enhanced risks of persistent negative emotions (Taft et al., 2007), it is reasonable
that the dynamic within the family could be affected. Findings on marital research has
confirmed associations between PTSD and higher levels of negative communication,
delay in attachment and bonding with a spousal partner, and incidences of marital conflict
related behavior (e.g., yelling, blaming) (Allen et al., 2010). The continuing pattern of
negative interaction and communication can further erode marital relationships over time
resulting in reduced marital satisfaction (Allen et al., 2018). Further, spouses were also
found to be at a higher risk of experiencing PTSD related symptoms compared to those
with spouses without the diagnosis (Dirkzwager et al., 2005). These findings provide
insight that close and intimate relationships may mediate the transmission of trauma.
Moreover, researchers report that higher risk of both physical assault (e.g., hitting) and
psychological aggression (e.g., being spiteful) toward one’s romantic or marital partner
are associated with PTSD status (Taft et al., 2007).
The impacts of PTSD can also be further transmitted to offspring. When service
members experience PTSD symptoms, their available resources, such as energy and time
for positive interaction with their children, can become limited (Cozza et al., 2005). In
addition, negative interactions between military personnel and their spouses have been
linked to diminished cooperation relevant to childcare (Allen et al., 2010). Thus, children
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of individuals with PTSD are exposed to distinct challenges that can limit positive
interactions between themselves and their parents. Studies have also documented some
negative impacts relevant to parenting with PTSD including higher levels of anxiety
(Lester et al., 2010). Based on this evidence, spouse and offspring of military service
members are at substantial risk for negative impacts associated with PTSD.
PTSD has also been linked to physical health of service members. Existing
studies reported enhanced risk for mortality among Vietnam War veterans (Boscarino,
2006). The study highlighted the need for further exploration of the underlying
behavioral, psychological, and physical health reasons behind this enhanced mortality
risk (Boscarino, 2006). Further, a study on specific causes of mortality relevant to heart
disease demonstrated consistent findings. Individuals with PTSD were found to be at
higher risk for death caused by cardiovascular disease (Boscarino, 2008). Another study
had similar findings that PTSD increased future risk for cardiovascular disease
(Beristianos et al., 2016). These health conditions have, in turn, affected various aspects
of life, sometimes long after the traumatic event(s) occured. A study reported that PTSD
was associated with lower life satisfaction thirty years after service members returned
from war (Koenen et al., 2008). PTSD has also impacted the utilization of healthcare.
Chan and colleagues discovered that veterans with PTSD or other mental health issues
had higher healthcare utilization (Chan et al., 2009). Considering the evidence of
spillover impact of PTSD beyond service members to family members, it is likely there is
spillover occurring in physical health, too. However, a major gap exists in the field as
there is no existing study exploring the impact of military service members’ PTSD on the
family members’ physical health. The current study aims to fill this gap in the field.
13
Proposed Conceptual Model
Based on the review of existing theory and studies, below is the proposed model
of PTSD and physical health (see figure 1). Existing evidence shows a connection
between psychological trauma and various physical health consequences (Ahmadi et al.,
2011; O’Donovan et al., 2014; Greenberg et al., 2014). Researchers have explored
potential underlying mechanisms; however, this connection is not yet fully understood.
The proposed model integrates the allostatic load model and the systemic impact model
of PTSD to understand the connection between PTSD and physical health in the context
of military families. This model has the potential to advance the understanding of the
relationship between PTSD and disease pathology, which in turn could aid in developing
prevention and intervention programming to minimize the impact of PTSD.
For the current model, the integration of the allostatic load model is intended to
help decipher the mechanism of psychological trauma and physical health. Allostasis and
allostatic load are two concepts that can be useful to understanding the mechanism.
Allostasis represents the adaptive changes that might occur following a traumatic stress
exposure, which may result in alterations of basic physical functions including heart rate
and blood pressure. Allostatic load refers to the accumulation of changes that occur as a
result of a significant event. In this model, allostatic load also represents an early
indication of pathology which includes inflammation. Overtime, allostatic load can
accumulate and develop to be allostatic overload. The clinical diagnosis of disease
represents the allostatic overload concept in the proposed model.
Evidence of the mental health impacts of PTSD on spouse and offspring have
been well documented. However, there is an existing gap of the knowledge on the
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physical health consequences associated with the PTSD diagnosis. The proposed model
aims to explain the interdependent nature of this psychological disorder and physical
health through various social interactions within the family. The knowledge gained can
provide a foundation for a psychological and physical health integrated program to
minimize the impacts of PTSD.
Allostasis: Physiological Responses to Stress
Exposure to trauma can activate the Stress Response System (SRS) in the human
body. The SRS serves as a mechanism for adaptation to internal or external threats
(Friedman & McEwen, 2003). The goal of the SRS is to enhance the odds of survival,
especially in an extreme situation. SRS pathways include: Autonomic Nervous System
(ANS) & Hypothalamus-Pituitary-Adrenal (HPA) (Gianaros & Wager, 2015).
The activation of SRS begins with exposure to a potential threat, then an appraisal
of the situation (Gianaros & Wager, 2015). During this phase, the individual evaluates the
situation and forms a perception relevant to the situation. Therefore, any stress appraisal
outcomes may vary from one individual to another, even when two individuals
experience the same event. The amygdala is an area of the brain involved in the appraisal
process (Hermann et al., 2014). Following the appraisal process, if an individual
perceives that there is a threat, then the brain signals either or both ANS and HPA to
activate.
The automatic nervous system (ANS) reacts to the presence of a threat by
increasing the sympathetic and decreasing parasympathetic activity (Gianaros & Wager,
2015). Sympathetic activity, also known as fight or flight response, is commonly present
during stressful situations, accompanied by alterations in heart rate and blood pressure.
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On the contrary, parasympathetic activity occurs during rest periods, which includes an
increase in energy conservation such as in the digestive system. If a threat is perceived to
be present, the amygdala sends a signal to the hypothalamus, which will then activate the
sympathetic nervous system (Brottman, Golden & Wittstein, 2007). In the context of
PTSD, alteration in arousal and sensitivity to stimuli related to a traumatic event are the
core features (APA, 2013). Accumulated evidence supports that veteran with PTSD have
higher blood pressure and faster heart rates (Buckley et al., 2004; Muraoka et al., 2005;
Bryant et al., 2008).
The other component of SRS is the Hypothalamic-pituitary-adrenal (HPA) axis
also begins with the appraisal process. During this process, the amygdala signals the
hypothalamus to send message to the pituitary to produce corticotropin releasing
factor/hormone (CRF/H) (Friedman & McEwen, 2004; Brottman et al., 2007). CFR then
travels to the pituitary gland to bind with the CRF receptor, which then will produce
adrenocorticotropic hormone (ACTH) (Brottman et al., 2007). Next, ACTH binds with
the designated receptor in the adrenal glands to produce cortisol (Brottman et al., 2007).
Cortisol is the hormone that is produced during stressful conditions and travels in the
blood to alter various systems in the body, including the immune system (Brottman et al.,
2007). Cortisol plays a role as a warning system which notifies various systems to fight
or flee in response to a threat. When it reaches an adequate level as required to handle the
stress, it sends out signal feedback to stop the ACTH production (Liu et al., 2017).
The exploration of HPA activity following a traumatic event has yielded mixed
findings. One study found enhanced levels of cortisol in victims three months following
an earthquake compared to baseline levels prior to the event (Kotozaki & Kawasima,
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2012). On the contrary, another study following individuals with PTSD showed lower
levels of cortisol compared to people without PTSD (Wessa et al., 2005). Additionally,
there is evidence of the connection between cortisol and inflammation levels. A study
discovered that higher levels of inflammatory agents, including tumor necrosis factor and
interleukin 6 (IL-6), were found in individuals with PTSD (Gill et al., 2008). Notably,
these individuals showed low levels of cortisol (Gill et al., 2008). Thus, the level of
cortisol may play a role in the immune system reaction in the context of PTSD. Further
investigation is needed to understand the differential effect following traumatic events.
The reaction to stress described above is designed for the short-term. In a situation
where the stress response system is activated for an extended period, it may result in
adverse health consequences for the individual (Gianaros & Wager, 2015). The nature of
PTSD symptoms, including arousal, hypervigilance, and flashbacks of traumatic
memories, may continuously alter the individual stress response system, long-term
(Friedman & McEwen, 2003). The extended alteration to SRS relevant to psychological
trauma has been associated with elevated risks for various health problems including
cardiovascular disease (Ahmadi et al., 2011; Beristianos et al., 2016). Despite the
established connection between the two, the relationship between pathology development
and PTSD is not well understood. Hence, incorporating the understanding of SRS may
contribute to the understanding of the mechanism linking the two.
Allostatic Load: Pre-Disease Biomarkers
Prolonged activation of the stress response system (SRS) can accumulate and
cause damage to the cells, tissues, and organs, as it is designed for temporary adaptation.
It can further lead to an inflammatory state, which can be a precursor for the later
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development of diseases, if it persists. PTSD is a mental health disorder characterized by
repeated and magnified fear responses relevant to trauma-related stimuli in the absence of
any actual threat (Michopoulos et al., 2017). Due to the nature of the disorder, individuals
with PTSD experience consistent activation of the SRS and are more vulnerable to
inflammation. Pro-inflammatory agents, including C-reactive protein (CRP) and IL-6,
have been well-studied in the context of PTSD investigations. However, these are not the
only indicators of inflammation. An alternative to the sophisticated and potentially costly
inflammatory agent tests is a blood test.
A blood test is a common procedure and is considerably more affordable
compared to most medical testing. It can provide various information including blood cell
count. Leukocyte count is one type of inflammation indicator that has been studied.
Exploration of other types of cells in conjunction with inflammation is needed. In the
current study, we will specifically study leukocytes, lymphocyte, neutrophils, and
platelets. Existing studies found increased levels of pro-inflammatory agents including
white blood count (leukocyte), specific components of leukocytes including lymphocyte
and neutrophils, and platelets among individual with PTSD (Boscarino & Chang, 1999;
Lindqvist et al., 2017; O’Donovan et al., 2017). These specific components of
inflammation will be further reviewed below.
Leukocytes. Leukocytes or white blood cells are thought to be an indicator of
inflammation in the body that is inexpensive and easily accessible to assess (Anderson et
al., 2007). Exposure to a psychological trauma can influence the production of cortisol,
which has an immunosuppressant quality that then affects the level of leukocyte produced
(Boscarino & Chang, 1999). A study reported that Vietnam Veterans with PTSD had a
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significantly higher level of leukocytes compared to those without PTSD, even twenty
years after trauma exposure (Boscarino & Chang, 1999). Similar findings of significantly
higher leukocyte levels were also detected among veterans from Operation Iraqi Freedom
and Operation Enduring Freedom (Lindqvist et al., 2017).
Further, leukocytes have also been found to play role in the pathology of diseases.
Leukocytes are involved in the inflammation process. The inflammation process could be
reparative, meaning it tells the body about damage or injury in certain areas and
kickstarts the healing process. However, if the inflammation stage lasts for an extended
period of time, it could cause permanent damage to the cells, tissues, and organs.
Findings consistently support the connection between leukocytes and various disease
including cardiovascular disease. A study reported that leukocyte levels serve as a
significant predictor for a cardiovascular event and mortality due to CVD (Horne et al.,
2005). The association also extends to peripheral arterial disease (Giugliano et al., 2010)
Despite some evidence that connects PTSD diagnoses, leukocyte levels, and
cardiovascular disease, there has been lack of research focused on evaluating the
relationship between the three variables together. Leukocyte levels may potentially serve
as a mechanism that explains the relationship between PTSD and CVD. It is also
important to highlight that if leukocyte levels serve as a mediator between PTSD and
CVD, it can also be used as an inexpensive monitoring procedure for at-risk individuals.
Neutrophils and Lymphocyte Ratio (N/L ratio). Leukocytes consist of a variety
of different types of cells. Each type of cells serves a distinct role in the inflammation
process. Neutrophil, for example, is a type of leukocyte that serves as a first responder in
the event of inflammation. It is the first cell that migrates to the inflamed site and attacks
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the external pathogens through phagocytosis (Rosales et al., 2017). Lymphocytes are
another cell-type that migrates to the injured site to do repair work. This specific type of
cell focuses on preventing the pathogen from multiplying (Koyasu & Moro, 2012). Both
neutrophils and lymphocytes provide information about the inflammatory site. However,
when combined as neutrophils and lymphocyte ratio (N/L ratio), further information on
health events, including mortality and morbidity, is given (Fest et al., 2019; Tokgoz et al.,
2018; Angkananard et al., 2018). The use of neutrophils and lymphocyte ratio is more
common in the medical field, especially in predicting specific outcomes relevant to
morbidity such as cardiovascular disease. A study by Hartaigh and colleagues (2012)
reported that both neutrophils and neutrophils/lymphocyte ratio were found to be
significant predictors for cardiovascular mortality. The same study suggested that
measures that involved neutrophils served as a better predictor than a contemporary
measure of inflammation such as C-reactive protein (CRP) (Hartaigh et al., 2012).
Despite some exploration of the relationship between PTSD and inflammation,
there are limited studies utilizing the neutrophils and lymphocyte ratio as an indicator of
inflammation. One study of veterans with PTSD reported significantly higher level of
neutrophils compared to those without PTSD (Lindqvist et al., 2017). However, the same
study reported a non-significant finding for the level of lymphocytes between groups
(Lindqvist et al., 2017). Another study on maltreated children documented different
levels of lymphocytes in maltreated children with PTSD compared to those without
PTSD (Bielas et al., 2012). Further exploration of the association between the neutrophils
and lymphocyte ratio and PTSD is needed.
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Platelet. The platelet is another component included in the complete blood count
(CBC) procedure. Platelets serve the function of terminating blood loss during internal
and external injury through the sealing of the damaged vessels (Willoughby et al., 2002).
On the other hand, platelets can also serve as a risk. In abnormal conditions, blood
vessels may have lesions as a result of high blood pressure. The lesion activates the
inflammation mechanism and recruit platelets to heal the damage. Therefore, information
on platelets may serve as an early indicator of underlying conditions and risk relevant to
cardiovascular disease. Studies have utilized platelets as a predictor of health outcomes.
One study reported that platelets are a significant predictor for cardiac mortality
(Goliasch et al., 2013). Another study found a positive association between platelets and
cardiovascular risk (Sloan et al., 2015).
Individuals with PTSD are found to have a higher platelet count compared to
those without (Lindqvist et al., 2017). As platelets play a role in the blood clotting
process during a blood clotting injury, a high count can result in spontaneous blood
clotting, which can impede blood and oxygen flow to important organs. Another study
reported the alteration in the reactivity of platelets following a traumatic event in a
sample of male Croatian veterans (Vidovic et al., 2011). This study found higher platelet
reactivity, meaning the platelets become more adhesive to different leukocyte types
enhancing the risk of developing atherosclerotic plaque, in those with PTSD compared to
those without PTSD (Vidovic et al., 2011). Higher platelet reactivity and the elevated
level of platelets can be disastrous as it can spontaneously lead to the development of
blood clotting and cause various problems including cardiovascular disease. Hence,
individuals with PTSD may potentially be at risk to develop cardiovascular disease.
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Allostatic Overload: Clinical Diagnosis of Disease
Prolonged SRS activation due to psychological trauma has been associated with
some negative health consequences, including cardiovascular disease (CVD) and sleep
disorder (Ahmadi et al., 2010; El-Gabalawy et al., 2018). Further details of each disease
diagnosis are provided in the following section.
Cardiovascular Disease (CVD). The World Health Organization (WHO) defined
CVD as various problems in the heart or blood vessels (WHO, 2017). Some examples of
CVD include coronary artery disease (CAD) and hypercholesterolemia. CVD contributes
to approximately 655,000 mortalities annually and is the leading cause of death in the
United States (CDC, 2020). Among those who suffer from CVD, many are military
service members and veterans. A Veteran Affairs’ report named cardiovascular disease as
the top leading cause of hospitalizations in the veteran affairs healthcare systems
(Veteran affairs, 2016). It raises question as to why the numbers are high among this
specific population.
CAD is one of the most common types of CVD to be found (CDC, 2017). It refers
to blockage in the artery, known as atherosclerosis, that causes the heart, and potentially
the rest of the body, to not receive proper oxygen and nutrient supply (CDC, 2017).
When CAD becomes so severe and reaches complete blockage, consequences may
include Myocardial Infarction (MI) or a stroke. MI, also known as a heart attack, is a
condition where the heart muscle starts to die as a result of blockage in arteries that
supply oxygen to the heart (American Heart Association, 2017). A stroke is another
condition that can emerge from the development of artery blockage (American Heart
Association, 2017). The blockage of blood vessels can result in either the death of brain
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cells because the brain does not get enough oxygen supply, which is known as an
ischemic stroke, or the vessel can burst as result of high blood pressure, which is known
as a hemorrhage stroke (American Heart Association, 2017). Atherosclerosis is also
found to consist of various immune system components which may indicate the role of
SRS in the pathology of atherosclerosis and CVD (Hansson et al., 2006).
Cardiovascular disease has been linked to various contributing factors from
genetic to environmental. Psychological trauma, as a form of extreme stress, is one factor
that has been studied. PTSD, a diagnosis relevant to psychological trauma, is associated
with an enhanced risk for cardiovascular disease (Ahmadi et al. 2011; Beristianos et al.,
2016). Nevertheless, the mechanism underlying disease pathology is not fully understood
although previous findings offer some insights. Individuals with PTSD were reported to
have higher systolic and diastolic BP and pulse rate (Paulus et al., 2013). In a separate
study, systolic BP was linked to enhanced risk of hemorrhagic stroke whereas pulse was
a predictor for peripheral arterial disease (Rapsomaniki et al., 2014). Additionally,
individuals with PTSD also showed higher inflammation, specifically higher white and
red blood cells, as well as a higher platelet count (Lindqvist et al., 2017). Taken together,
these alterations following a PTSD diagnosis may suggest key variables that are involved
in the pathology of cardiovascular disease linked to psychological trauma.
Sleep disorders. The American Psychiatric Association (APA) defines sleep
disorders as any significant disturbances in sleep pattern and quality that impact
individual ability to perform normal functions (APA, 2013). Some examples of sleep
disorders include insomnia and nightmare disorder (APA, 2013). Inevitably, the quality
of sleep and sleep disorder are relevant topics to PTSD, as some of the symptoms overlap.
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PTSD symptoms can include intrusion symptoms and alteration of arousal (APA, 2013).
Intrusion symptoms can manifest as nightmares, which can disrupt one’s sleep pattern
and quality. Further, the alteration of arousal symptoms may also be exhibited as sleep
disturbances such as insomnia. These symptoms of PTSD can impact the quality of sleep,
which, if extended for a period of time, can meet the criteria for sleep disorders.
The connection of PTSD and sleep disorders have been documented in military
and veteran populations. Existing literature documented that military service members
experienced significant sleep problems (Plumb et al., 2014; Straus et al., 2015), and some
received diagnoses of sleep disorders specifically called insomnia (Mysliwiec et al.,
2012). One study discovered that significant disturbances of sleep are more profound
during and after a deployment period (Seelig et al., 2010). Another study revealed that
the severity of PTSD symptoms and sleep problems are related (Plumb et al., 2014).
Despite the established association between PTSD and sleep problems, there has been a
lack of attempts to systematically understand the relationship between the two. An article
points at this gap and further raises the question of whether sleep disorder is a feature of
PTSD or an impact of PTSD due to physical changes following psychological trauma
(Spoormaker & Montgomery, 2008). Unfortunately, the lack of understanding of the
connection between the two hinders the development of an effective treatment. The
proposed model in the current study offers the potential to understand the contribution of
alteration in physiological responses and inflammation in the development of sleep
disorders.
Sociodemographic Characteristics. The influence of sociodemographic
characteristics in various outcomes have been well-studied, especially in the field of
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social science. These are considered to be key factors, as sociodemographic
characteristics provide context for the human experience. Specifically, in the study of
psychological trauma, sociodemographic characteristics have a distinct role. In some
cases, they contribute to creating an enhanced risk to exposure of trauma. On the contrary,
they can also buffer the negative impacts of trauma. The current study will focus on sex,
age, and race as key characteristics. In the next section, each sociodemographic
characteristic is further discussed.
Sex. There is ample evidence surrounding sex differences in both mental and
physical health. In the context of psychological trauma, for example, researchers have
reported stronger association between combat exposure and PTSD in military service
female than what is found in their male counterparts (Luxton et al., 2010). Another study
discovered distinct symptom differences of PTSD between males and females. Males
appeared to show more numbing symptoms compared to females (Hourani et al., 2015).
The processes that differentiate these trauma symptoms between the two sexes are still
unclear. On the physical health side, the evidence of sex differences is also salient. In a
study of cardiovascular risk, older women had multiplied risk of mortality due to
cardiovascular compared to women (Regnault et al., 2012).
Existing evidence also points to women as having higher vulnerability for both
PTSD and health problems, specifically CVD. There is limited research on sex
differences in the area of sleep hygiene and sleep disorder. Further investigation for
understanding better the role of sex differences in the area of psychological trauma is
needed, as well.
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Age. Age is another important determinant in one’s health functioning. Generally,
individuals experience decreases in physical health functioning overtime (Ferraro &
Farmer, 1996). As an individual ages, the function as well as structure of various organs
also change. For example, in one study the liver showed declined function as individual
aged (Zeeh & Platt, 2002). The changes on cells, organs, tissue structures and their
functions can alter the relationship between PTSD and physical health. Thus, age can
serve as a moderator in the PTSD-physical health association.
Race. Further, race also contributes to our understanding of health. Disparities in
health status between white individuals and other minority groups (e.g., African
Americans) has been long standing and well-documented (Williams et al., 2016). A study
showed that African American individuals experienced more chronic and serious illness
across their lifespan in comparison to White Caucasians (Ferraro & Farmer, 1996). The
differences in health status stems from the issue of racial discrimination that led to
deprived access to health resources. The current study investigates whether the finding of
health disparities between races extends to the context of the PTSD and physical health
relationship.
Body Mass Index (BMI). BMI is a ratio of weight and height measured in
kilogram per square meter (Center for Disease Control, 2020). It is a health indicator
commonly used as a proxy to measure of body fat (CDC, 2020). According to the CDC
(2020), BMI can be categorized into one of four groups; under 18 is considered
underweight, between 18.5 and 24.9 is considered normal, 25.0 to 29.9 is considered
overweight, and above 30 is considered obese. BMI has been linked to the general risk of
morbidity and mortality (Zhai et al., 2020; Lung et al., 2019; Konnopka et al., 2011;
26
Zheng et al., 2013). One epidemiology study discovered the BMI trajectory after the age
of 51 is a more significant predictor compared to the BMI status at a single point of time
(Zheng et al., 2013). Another study also confirmed that individuals with healthy BMI
have the lowest mortality risk compared to overweight and obese individuals (de
Gonzales et al., 2010). Additionally, Konnopka and colleagues (2011) found that obesity
was associated with high healthcare cost, including from cardiovascular disease.
Further, existing literature has established an association between BMI and PTSD.
In a study of military veterans, BMI was explored as a potential negative effect of PTSD
(Smith et al., 2015). The findings showed that the current positive PTSD status was
linked to an increased risk of being overweight or obese, especially for the older adult
population (Smith et al., 2015). Another study also found that BMI was increased to meet
the overweight or obese category in the presence of PTSD symptoms (Kubzansky et al.,
2014). Following a psychological trauma, poor health behaviors including a lack of
exercise, unhealthy food consumption, and substance use may emerge as a form of
coping response (Hoerster et al., 2019). These types of behaviors could affect one’s
health status including BMI. Interestingly, there is a lack of research exploring the risk of
PTSD for those in certain BMI groups.
Further, BMI has also been linked to specific health problems including
cardiovascular diseases. Khan and colleagues (2018) found that obese and overweight
individuals have a higher risk of developing CVD, experiencing a cardiovascular event,
and mortality compared to those with normal BMI. Further, the risk increases with age
(Khan et al., 2018). In this case, BMI serves as a proxy measure of health status provide a
slice of information of health status. BMI that falls into overweight and obese categories
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could indicate poor nutrition intake (e.g., junk food), or a sedentary lifestyle that has been
linked to impact aspects of cardiovascular health such as blood pressure or the
development of plaque in the blood vessel.
Initial evidence showed association between BMI and sleep disorder and quality.
One study discovered that those who are overweight or obese have less hours of sleep
than those with normal BMI (Vorona et al., 2005). Interestingly, this relationship is
reversed in the extreme obese category, where the number of sleeping hours is
dramatically increased (Vorona et al., 2005). Further, a study reported that individuals
with BMI larger than 32 were at higher risk for a sleep disorder, specifically obstructive
sleep apnea (Morris et al., 2008).
Proposed Analytical Model and Hypotheses
Based on the conceptual model described in the previous section, an analytical
model with key variables that represent the concepts is proposed (see Figure 2). This
analytical model will be used to answer the broader question: How does PTSD influence
physiological response and disease among active military servicemembers? To answer
this question, the following hypotheses will be addressed.
Hypothesis 1: Higher physiological stress response is associated with higher pre-
disease biomarkers prior to PTSD diagnosis.
1A.1 Higher systolic BP is associated with a higher leukocyte count prior to PTSD
diagnosis.
1A.2 Higher systolic BP is associated with a higher platelet count prior to PTSD
diagnosis.
1A.3 Higher systolic BP is associated with a higher N/L ratio prior to PTSD diagnosis.
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1B.1 Higher diastolic BP is associated with a higher leukocyte count prior to PTSD
diagnosis.
1B.2 Higher systolic BP is associated with a higher platelet count prior to PTSD
diagnosis.
1B.2 Higher diastolic BP is associated with a higher N/L ratio prior to PTSD diagnosis.
1C.1 Higher pulse rate is associated with a higher leukocyte count prior to PTSD
diagnosis.
1C.2 Higher pulse rate is associated with a higher platelet count prior to PTSD diagnosis.
1C.3 Higher pulse rate is associated with a higher N/L ratio prior to PTSD diagnosis.
Hypothesis 2: Higher pre-disease biomarkers is associated with a higher risk of
being diagnosed with PTSD.
2A. Higher leukocyte count is associated with a higher risk of being diagnosed with
PTSD.
2B. Higher platelet count is associated with a higher risk of being diagnosed with PTSD.
2C. Higher N/L ratio is associated with a higher risk of being diagnosed with PTSD.
Hypothesis 3: Diagnosis of PTSD is associated with higher physiological responses.
3A. Diagnosis of PTSD is associated with higher systolic blood pressure.
3B. Diagnosis of PTSD is associated with higher diastolic blood pressure.
3C. Diagnosis of PTSD is be associated with higher pulse rate.
Hypothesis 4: Diagnosis of PTSD is associated with higher pre-disease biomarkers.
4A. Diagnosis of PTSD is associated with higher leukocyte counts.
4B. Diagnosis of PTSD is associated with higher platelet counts.
4C. Diagnosis of PTSD is be associated with higher N/L ratio.
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Hypothesis 5: PTSD diagnosis is associated with a higher risk of pathology.
5A. PTSD diagnosis is associated with a higher risk of cardiovascular disease.
5B. PTSD diagnosis is associated with a higher risk of sleep disorder.
Hypothesis 6: Higher physiological responses is associated with higher pre-disease
biomarkers.
6A. Higher blood pressure systolic is associated with higher pre-disease biomarkers.
6A.1 Higher blood pressure systolic is associated with higher leukocyte count.
6A.2 Higher blood pressure systolic is associated with higher platelet count.
6A.3 Higher blood pressure systolic is associated with higher N/L ratio
6B. Higher blood pressure diastolic is associated with higher pre-disease biomarkers.
6B.1 Higher blood pressure diastolic is associated with higher leukocyte count.
6B.2 Higher blood pressure diastolic is associated with higher platelet count.
6B.3 Higher blood pressure diastolic is associated with higher N/L ratio
6C. Higher pulse rate is associated with higher pre-disease biomarkers.
6B.1 Higher pulse rate is associated with higher leukocyte count.
6B.2 Higher pulse rate is associated with higher platelet count.
6B.3 Higher pulse rate is associated with higher N/L ratio
Hypothesis 7: Higher physiological responses is associated with higher risk for
pathology.
7A. Higher systolic BP is associated with higher risk for pathology.
7A.1 Higher systolic BP is associated with higher risk for CVD.
7A.2 Higher systolic BP is associated with higher risk for sleep disorder.
7B. Higher diastolic BP is associated with higher risk for pathology.
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7B.1 Higher diastolic BP is associated with higher risk for CVD.
7B.2 Higher diastolic BP is associated with higher risk for sleep disorder.
7C. Higher pulse rate is associated with higher risk for pathology.
7C.1 Higher pulse rate is associated with higher risk for CVD.
7C.2 Higher pulse rate is associated with higher risk for sleep disorder.
Hypothesis 8: Higher level of pre-disease biomarkers is associated with higher risk
for pathology.
8A. Higher leukocytes count is associated with higher risk for pathology.
8A.1 Higher leukocytes count is associated higher risk for CVD.
8A.2 Higher leukocytes count is associated higher risk for sleep disorder.
8B. Higher platelet count is associated with higher risk for pathology.
8B.1 Higher platelet count is associated with higher risk for CVD.
8B.2 Higher platelet count is associated with higher risk for sleep disorder.
8C. Higher N/L ratio is associated with higher risk for pathology.
8C.1 Higher N/L ratio is associated with higher risk for CVD.
8C.2 Higher N/L ratio is associated with higher risk for sleep disorder.
Hypothesis 9: The diagnosis of cardiovascular disease is associated with the
diagnosis of sleep disorder.
Hypothesis 10: Physiological responses mediate the association between PTSD and
pre-disease biomarkers following PTSD diagnosis.
10A. Systolic BP mediates the relationship between PTSD and pre-disease biomarkers.
10A.1 Systolic BP mediates the relationship between PTSD and leukocyte count.
10A.2 Systolic BP mediates the relationship between PTSD and platelet count.
31
10A.3 Systolic BP mediates the relationship between PTSD and N/L ratio.
10B. Diastolic BP mediates the relationship between PTSD and pre-disease biomarkers.
10B.1 Diastolic BP mediates the relationship between PTSD and leukocyte count.
10B.2 Diastolic BP mediates the relationship between PTSD and platelet count.
10B.3 Diastolic BP mediates the relationship between PTSD and N/L ratio.
10C. Pulse rate mediates the relationship between PTSD and pre-disease biomarkers.
10C.1 Pulse rate mediates the relationship between PTSD and leukocyte count.
10C.2 Pulse rate mediates the relationship between PTSD and platelet count.
10C.3 Pulse rate mediates the relationship between PTSD and N/L ratio.
Hypothesis 11: Pre-disease biomarkers mediate the relationship between
physiological responses and pathology.
11A. Leukocyte count mediates the relationship between physiological responses and
pathology.
11A.1 Leukocyte count mediates the relationship between systolic BP and CVD.
11A.2 Leukocyte count mediates the relationship between systolic BP and sleep
disorder.
11A.3 Leukocyte count mediates the relationship between diastolic BP and CVD.
11A.4 Leukocyte count mediates the relationship between diastolic BP and sleep
disorder.
11A.5 Leukocyte count mediates the relationship between pulse rate and CVD.
11A.6 Leukocyte count mediates the relationship between pulse and sleep
disorder.
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11B. Platelet count mediate the relationship between physiological responses and
pathology.
11B.1 Platelet count mediates the relationship between systolic BP and CVD.
11B.2 Platelet count mediates the relationship between systolic BP and sleep
disorder.
11B.3 Platelet count mediates the relationship between diastolic BP and CVD.
11B.4 Platelet count mediates the relationship between diastolic BP and sleep
disorder.
11B.5 Platelet count mediates the relationship between pulse rate and CVD.
11B.6 Platelet count mediates the relationship between pulse rate and sleep
disorder.
11C. N/L ratio mediates the relationship between physiological responses and pathology.
11C.1 N/L ratio mediates the relationship between systolic BP and CVD.
11C.2 N/L ratio mediates the relationship between systolic BP and sleep disorder.
11C.3 N/L ratio mediates the relationship between diastolic BP and CVD.
11C.4 N/L ratio mediates the relationship between diastolic BP and sleep disorder.
11C.5 N/L ratio mediates the relationship between pulse rate and CVD.
11C.6 N/L ratio mediates the relationship between pulse rate and sleep disorder.
Hypothesis 12: Physiological responses and pre-disease markers mediate the
relationship between PTSD and pathology.
12A. Systolic BP and leukocyte count mediate the relationship between PTSD and
pathology.
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12A.1 Systolic BP and leukocyte count mediate the relationship between PTSD
and CVD.
12A.2 Systolic BP and leukocyte mediate the relationship between PTSD and
sleep disorder.
12B. Systolic BP and platelet count mediate the relationship between PTSD and
pathology.
12B.1 Systolic BP and platelet count mediate the relationship between PTSD and
CVD.
12B.2 Systolic BP and platelet count mediate the relationship between PTSD and
sleep disorder.
12C. Systolic BP and N/L ratio mediate the relationship between PTSD and pathology.
12C.1 Systolic BP and N/L ratio mediate the relationship between PTSD and
CVD.
12C.2 Systolic BP and N/L ratio mediate the relationship between PTSD and
sleep disorder.
12D. Diastolic BP and leukocyte count mediate the relationship between PTSD and
pathology.
12D.1 Diastolic BP and leukocyte count mediate the relationship between PTSD
and CVD.
12D.2 Diastolic BP and leukocyte count mediate the relationship between PTSD
and sleep disorder.
12E. Diastolic BP and platelet count mediate the relationship between PTSD and
pathology.
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12E.1 Diastolic BP and platelet count mediate the relationship between PTSD and
CVD.
12E.2 Diastolic BP and platelet count mediate the relationship between PTSD and
sleep disorder.
12F. Diastolic BP and N/L ratio mediate the relationship between PTSD and pathology.
12F.1 Diastolic BP and N/L ratio mediate the relationship between PTSD and
CVD.
12F.2 Diastolic BP and N/L ratio mediate the relationship between PTSD and
sleep disorder.
12G. Pulse rate and leukocyte count mediate the relationship between PTSD and
pathology.
12G.1 Pulse rate and leukocyte count mediate the relationship between PTSD and
CVD.
12G.2 Pulse rate and leukocyte count mediate the relationship between PTSD and
sleep disorder.
12H. Pulse rate and platelet count mediate the relationship between PTSD and pathology.
12H.1 Pulse rate and platelet count mediate the relationship between PTSD and
CVD.
12H.2 Pulse rate and platelet count mediate the relationship between PTSD and
sleep disorder.
12I. Pulse rate and N/L ratio mediate the relationship between PTSD and pathology.
12I.1 Pulse rate and N/L ratio mediate the relationship between PTSD and CVD.
35
12I.2 Pulse rate and N/L ratio mediate the relationship between PTSD and sleep
disorder.
Hypothesis 13: Sex, race age, and BMI moderate the proposed model
13A. Sex moderate relationships in the proposed model.
13B. Race moderate the relationships in the proposed model.
13C. Age moderate the relationships in the proposed model.




Description of the Data
Data analytics for this study utilized a secondary dataset from CERNER Health
Facts® (Cerner-HF). Cerner-HF is a HIPAA compliant dataset based on patients’
electronic health records (EHR) managed by the Center for Health System Innovation
(CHSI) at Oklahoma State University. CERNER-HF data includes 63 million patients
and 380 million observations since 2000 and is donated by more than 600 CERNER
hospitals and clinics across the United States (CHSI, 2019).
EHR has been reported to have many potential benefits for patients, providers,
and overall quality of healthcare services. The integrated health data allows transparency
and accessibility for the patients. This allows for patients to be educated and involved in
the decision-making process relevant to their health. The consistency of treatment across
healthcare providers could be subjective especially if the information relevant to the prior
treatment is not easily available. This absence of key information could affect the quality
of care. The accessibility of EHR could also help ease the transfer process
betweenproviders. EHR also provides a platform to monitor the quality of care, which
could be beneficial for all parties. For providers, this may mean that they could use this
tool to maintain excellent services for the patients and for the administrators and it could
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serve as a resource for understanding the quality care provided within their
healthcare office.
Beyond improving the quality of healthcare services, EHR could also serve the
purpose of advancing our understanding of health. her, as an integrated data registry,
allows extensive and longitudinal data to be collected without additional cost, which
would be an excellent tool for research. EHR data could be beneficial for health trend
monitoring process and in turn, the findings could be used for program and policy
development. Therefore, the program and policy will be more targeted in the area where
it is needed. EHR has been utilized in some studies in the fields of medical science,
public health, and epidemiology. However, EHR is a novel data type to also be used in
the social sciences research. In the context of the current study, EHR provided a unique
opportunity to understand the connection between mental health and physical health
diagnosis.
Participants
The sample was obtained through data mining from the full data set of EHR of 63
million patients. The sole inclusion criterion in the current study was military insurance
(previously known as CHAMPUS). If the individual utilized this military insurance
coverage at least once with the health service they obtained from CERNER hospitals or
clinics, then they were eligible to be included in the sample. In addition to military
personnel, any spouse and/or dependent of military personnel are eligible for the health
insurance coverage therefore, it is important to note that military personnel,
spousesand/or dependents were potentially included in the current study. After applying
the inclusion criteria and narrowing down the visits to a maximum of three for each
38
patient. In the final data included for the analysis, there were approximately 280,000
encounters from 18,253 patients ranging in age between 0 and 90 years. Thirty-four
percent of patients are male, and thirty-three percent are female. However, thirty-two
percent of participants did not report their gender. Forty-nine percent of the sample were
White Caucasian and fourteen percent were non-White. Thirty-six percent did not report
their race. Of total sample, 12,042 patients did not have a PTSD diagnosis and 6,211
(34.03%) had been diagnosed with PTSD.
Procedure
Access to CERNER Health Facts® requires a procedural request through the
CHSI at Oklahoma State University. Due to the size of the full CERNER-HF dataset,
researchers are required to submit criteria to create sample of the data. For the current
study, the inclusion criterion is patients who utilized military insurance. The data
included various aspects of EHR such as diagnoses, lab procedures, medication and
treatment, clinical events, and demographics of patients. For the purpose of the current
study, only data on diagnosis, laboratory procedures and demographic information of
patients were included in the final dataset.
Additional data management and cleaning was conducted using STATA 16. To
establish temporal precedence in the data, PTSD had to be diagnosed prior to any
cardiovascular, or sleep disorder, otherwise the patients were dropped from the data.
Then, researcher identified a time point before and after the patients’ PTSD diagnosis.
Hence, each participant had a maximum of three data points. Afterwards, additional
screening for outliers was conducted using descriptive statistic and any outliers found
were eliminated. After data cleaning and management steps were completed, data
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Information on age, sex, and race were obtained from the data. Age was coded into
one of the age groups; 0-17 years coded as 1, 18-49 years coded as 2, and 50 years and
older coded as 3. Sex was coded 0 = male, and 1 = female. Race was coded 0 = white,
and 1 = non-white.
PTSD
In the current study, disruption in functioning resulting from a psychological
trauma was measured by a clinical diagnosis of Posttraumatic Stress Disorder (PTSD).
The diagnosis was based on ICD 9-CM or ICD 10-CM. The PTSD code for ICD 9-CM
309.81 and for ICD-10-CM F43.10 for PTSD unspecified, F43.11for PTSD acute and
F43.12 for PTSD chronic. Diagnoses of Posttraumatic Stress Disorder were conducted by
health professionals. The presence of psychological trauma was transformed into
dummy-code variable (0 = no PTSD, 1 = has PTSD diagnosis) based on the diagnosis
code variable in the original dataset.
Physiological Stress Response
Physiological stress was assessed through vital signs. Vital signs were measured
on each visit. For purposes of this study, information of physiological stress was obtained
from the visit prior to PTSD diagnosis and after the diagnosis listed. Vital signs based on
objective clinical measures of systolic and diastolic blood pressure (BP) and pulse rate
serve as the primary assessment indicators of physiological stress.
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Blood Pressure (BP). BP contains two measurements: systolic and diastolic. Both
systolic and diastolic were measured in millimeters of mercury (mmHg). Systolic BP
refers to the pressure of the blood against the wall of the heart while the heart pumps
blood to the rest of the body. Diastolic BP refers to the pressure of blood against the
wall while blood enters the heart.
Pulse Rates. Pulse rates refers to the speed of the contraction of the heart in a minute.
It is also known as heart rate. It is measured in beats per minute (BPM unit). In the
current study, pulse was measured during each visit to the CERNER hospitals/clinic.
AHA specified normal heart rates are between 60-100 BPM.
Pre-Disease Biomarkers
Information on pre-disease stage were obtained from the laboratory test result
relevant to inflammation. Inflammation is an immune system reaction toward any threat
including stress or pathogen. In the proposed model, the pre-disease stage was indicated
by inflammation measured through immune system reactions including leukocyte,
platelet, and neutrophils/lymphocytes ratio. Leukocyte or white blood cell count were
used as indicators of immune system reaction. Platelet is a blood cell component that
plays important role on clotting. Leukocyte and platelet were measured in thousand per
microliter (103/ μl). Neutrophils is a type of white blood cell that has a specific role in
restoring damage tissues and reducing infection. On the other hand, lymphocytes are a
different type of leukocyte that plays role in destroying invaders including virus and
bacteria. The ratio of neutrophils and lymphocytes indicates systemic inflammation.
Information on pre-disease biomarkers is only limited to some participants who were
required to have the test done due to their condition.
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Pathology
In the current study, the main outcome of interest was the diagnosis of diseases.
The diagnosis process was conducted by health professionals and listed in the dataset as
ICD 9-CM and 10 codes as well as the disease name. Diagnosis was only included if the
date of diagnosis occured after the date of diagnosis for PTSD. Further, there are two
types of disease groups that were included in the analysis: cardiovascular disease (CVD),
and sleep disorder. Below is further description of each disease.
Cardiovascular Disease (CVD). CVD is defined as various type of diseases that are
located in the heart and vascular system. An example of a CVD is myocardial
infarction, which listed as 410 – 414 in ICD 9-CM and I21 – I23, I29 in ICD 10. For
the purpose of the current study, the absence of CVD was recoded as 0, or 1 if there
was evidence of one or more CVD diagnosis. Additionally, any congenital heart
disease was also excluded from analysis.
Sleep Disorder. Sleep disorders are various conditions that affect the quality of sleep.
Insomnia and nightmare disorder are examples of sleep disorders. Night terror is
listed with 307.46 in ICD-9 CM F51.4 in ICD 10. Based on the information on EHR,
the presence of any sleep disorder was coded as 1 whereas 0 represented no
diagnosis of a sleep disorder.
Analytical Procedure
In the current study, the data analysis process began with data cleaning and
management. After data cleaning and management were completed, descriptive analysis
was conducted followed by the path analysis and multiple groups analysis. Further
description of each step is provided below.
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Data cleaning and management were conducted prior to analyzing the proposed
model using STATA 16 software. Initial descriptive statistics analysis including
frequencies, means, and standard deviation were conducted to obtain basic information of
the data. Based on the descriptive statistics, the researcher identified any missing data,
outliers, and recoded variables. The normal range of each variable listed in the literature
review were used to determine whether or not to drop the data. Further, some variables
were also recoded as described in the variable section. In addition to descriptive analysis,
correlation between variables were also examined to evaluate relationships between
variables in the proposed model.
After data cleaning and management process were completed, the analysis was
then proceeded using MPLUS 8. Path analyses were utilized to evaluate hypothesis 1
through 9. Indirect effects stated in hypotheses 10, 11 and 12 were also included in this
analysis. MLR estimation was utilized. Further, due to the amount of missing data in the
current study, Monte Carlo estimation were also utilized. Global fit statistics were not
available for the current model. Path analysis is a structural equation method of analysis
used to evaluate the fit of a proposed model with the data (Kline, 2006).
There are several recommended steps involved in conducting structural equation
modeling (SEM) including model specification, identification, evaluation of the model fit,
interpretation of estimates, consideration of equivalent or near-equivalent models, and
reporting results (Kline, 2011). In the current study, a model has been specified and
identified based on comprehensive literature reviews of the variables. To evaluate
hypothesis 13, the researcher utilized a mixture modeling to evaluate the path analysis for
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multiple group comparison. MLR and Monte Carlo estimations were also utilized for this
model.
Rescaling of variables
Given the significant findings but smaller parameter yielded from the proposed
model, rescaling was conducted for interpretability. The rescaled variables included
systolic and diastolic BP, pulse rate, leukocyte count, platelet count, and N/L ratio both in
pre-PTSD, and post-PTSD models. For systolic and diastolic BP, the variables were
rescaled by multiplying them to 100. Similarly, pulse rate was also rescaled to 100.
Leukocyte count and N/L ratio were rescaled to 10 times the original and platelet count
was multiplied and rescaled to 1000 times the original.
Delimitations
The data for the current study has some potential limitations that are explained in
this section. First, the data was collected and entered by a third party, which
leavespotential for the method of data collection not being consistent across participants.
Unfortunately, CHSI was unable to provide the questionnaire used to collect data. Further,
the data were based on objective measures from EHR. The potential downside of
objective measures, specifically in the area of the current study, is that we were unable to
capture the subjective aspect of patients’ experience. Another potential limitation is that
there was no available identification of whether the patient was an active military
servicemember or military dependent. Thus, it was not possible to evaluate the difference
in impact for active military members who may have been directly involved in combat




Associations between physical responses, pre-disease biomarkers, PTSD, and
pathology before and after a traumatic experience emerged from the proposed model
using structural equational modeling, specifically path analysis and multiple group path
analysis (see Figure 2). The physiological responses and pre-disease biomarkers were
evaluated prior to a PTSD diagnosis. Physiological responses included three different
measures: systolic and diastolic BP and pulse rate. Pre-disease biomarkers included
leukocyte count, platelet count, and neutrophil to lymphocyte ratio (N/L ratio). Further,
physiological responses, pre-disease biomarkers, and pathology were also examined in
the aftermath of a PTSD diagnosis. Sleep disorder and cardiovascular disease were
specific pathologies that were included in the proposed model. Beyond the direct paths
between aforementioned variables, indirect path associations within the proposed model
were also evaluated.
Full Model
The full model is presented in Figure 3 and included 13,314 individuals. In the
pre-PTSD model, the analysis indicated both positive and negative relationships between
the physiological responses and pre-disease biomarkers. A significant path between pulse
rate and leukocyte count (β = 0.293, p = 0.004) was found, which means that for a ten
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beat per minute increase in pulse rate, the leukocyte counts increased by 293
leukocyte count per microliter. A positive relationship was also found between systolic
BP and platelet count (β = 0.055, p = 0.005). A ten mmHg boost in systolic BP was
associated with an elevation of 550 platelet count per microliter. These findings offered
some support for the connection between physiological responses and pre-disease
biomarkers as stated in the first hypothesis. On the contrary, evidence of the opposite
relationship was also noted; an increase in diastolic BP by 10 mmHg was significantly
associated with a lowering of 0.343 in N/L ratio (β = -0.343, p = 0.026). Further, when
the leukocyte count increased by a thousand count per microliter, the risk for a diagnosis
of PTSD was augmented by 2.28 (β = 0.228, p = 0.007), which supported the second
hypothesis that proposed connection between pre-disease biomarker and the risk of being
diagnosed with PTSD. The pre-PTSD model provided some insights into the
physiological profiles associated with the risk of being diagnosed with PTSD.
Further, the model also evaluated various physiological impacts of PTSD. PTSD
was found to impact physiological responses, pre-disease biomarkers, and pathology. In
fact, having a PTSD diagnosis altered physiological responses differently, as it was noted
to reduce the systolic BP by 3.4 mmHg (β = 0.034, p < 0.001), and elevated pulse rate by
2.9 bpm (β = 0.029, p < 0.001). Individuals who have PTSD diagnosis were found to
have 1.04 unit lower in N/L ratio (β = -0.104, p = 0.027). Being diagnosed with PTSD
was also associated with 0.093 higher likelihood of being diagnosed with cardiovascular
disease (β = 0.093, p < 0.001) and 0.121 higher risk for sleep disorder (β = 0.121, p <
0.001). These findings provided some support for hypothesis 3, 4, and 5.
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The model also yielded evidence of relationships between physiological responses,
pre-disease biomarkers, and pathology. In the current model, when the pulse rate was
faster by 10 bpm, the leukocyte count also increased by 330 per microliter (β = 0.330, p
< 0.001), 5000 platelet count per microliter (β = 0.050, p = 0.001), and 0.656 in N/L ratio
(β = 0.656, p < 0.001). In addition, higher systolic BP by 10 mmHg was also found to
predict 4900 count per microliter elevation of platelet count (β = 0.049, p = 0.001). These
significant paths supported the sixth hypothesis positing an association between
physiological responses and pre-disease biomarkers. However, two significant paths
suggested different effects. A ten mmHg increase in systolic BP was associated with 86
leukocyte count per microliter decrease (β = -0.086, p < 0.035) and 0.757 N/L ratio lower
(β = -0.757, p < 0.001). Further, both physiological responses and pre-disease biomarkers
were also examined to predict pathology. Ten bpm slower pulse rate projected
significantly 0.005 higher risk for CVD (β = -0.059, p = 0.006) and marginal risk for
sleep disorder (β = -0.033, p = 0.054). Lower diastolic BP by ten mmHg also predicted
0.004 higher risk for being diagnosed with CVD (β = -0.040, p = 0.006). Additionally,
two pre-disease biomarkers significantly predicted CVD. When platelet count lowered by
1000 count per microliter, it reflected higher risk of 0.248 for CVD (β = -0.248, p <
0.001). A ten unit increase in N/L ratio suggested 0.026 increase of CVD risk (β = 0.026,
p < 0.001). However, only a thousand decrease in platelet count was associated with
0.077 of increase risk for sleep disorder (β = -0.077, p = 0.030). The current findings of
positive relationships of both physiological responses and pre-disease biomarkers with
the risk of being diagnosed with disease suggests support for hypothesis 7 and 8.
Moreover, there was also evidence of comorbidity between CVD and sleep disorder (β =
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0.009, p < 0.001), which provided support for hypothesis 9. Taken together, these
findings indicate connections between all three variables which can offer insights into the
mechanism linking PTSD and pathology.
Beyond the examination of direct effects, the current study also evaluated indirect
path associations in the aftermath of PTSD. First, evidence of significant indirect paths
between physiological responses and pathology via pre-disease biomarkers were noted. A
total indirect effect that connects systolic BP to the risk of being diagnosed with CVD
was found to be significant (β = -0.033, p < 0.001), specifically through platelet count (β
= -0.012, p = 0.002), and N/L ratio (β = -0.020, p < 0.001). Two specific indirect paths
between pulse rate and CVD mediated by platelet count (β = -0.013, p = 0.001) and N/L
ratio (β = 0.017, p < 0.001) were also found to be significant. Another total indirect effect
between systolic BP and sleep disorder was also found (β = -0.010, p = 0.030). This path
was significantly mediated by platelet count (β = -0.004, p = 0.044). A significant
specific indirect effect between pulse and sleep disorder was also found, specifically
through platelet count (β = -0.004, p = 0.042). The indirect model also yielded significant
total and specific indirect effects between PTSD and pre-disease biomarker mediated by
physiological responses. Two total indirect effects connected PTSD and leukocyte count
(β = 0.012, p < 0.001) and N/L ratio (β = 0.047, p < 0.001). Both of the total indirect
effects were mediated by diastolic BP (βleukocyte = 0.003, p = 0.047; βN/Lratio= 0.026, p <
0.001) and pulse rate (βleukocyte = 0.010, p = 0.003; βN/Lratio = 0.019, p = 0.003). Two
additional specific indirect effects were also found that connected PTSD and platelet
mediated by diastolic BP (β = -0.002, p = 0.003) and pulse rate (β = 0.001, p = 0.009).
Moreover, six specific indirect effects were also discovered in the model. The connection
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between PTSD and CVD was mediated by pulse (β = -0.002, p = 0.047) and N/L ratio (β
= -0.003, p = 0.022). The same indirect path was also mediated by diastolic BP and
platelet (β = 0.000, p = 0.006), pulse rate and platelet count (β = 0.000, p < 0.006),
diastolic BP and N/L ratio (β = 0.001, p = 0.002), as well as pulse rate and N/L ratio (β =
0.001, p = 0.011). Based on the evaluation of indirect model, there was some evidence of
hypothesis 10, 11, and 12. Overall, findings from direct effects and indirect effects
suggested some mechanism that connects PTSD and pathology.
Multiple Group Analysis
Multiple groups analysis was also conducted to compare the paths and evaluate
potential moderation effects as stated in hypothesis 12. In the current study, multiple
group analysis was conducted to compare the full model with sex, race, age, and body
mass index (BMI). Further details on the findings of these analyses are provided below.
Sex
A multiple group analysis was conducted to compare the proposed model for the full
model (see Figure 3), males (see Figure 4) and female participants (see Figure 5). Direct
effect results for the full model are displayed in Table 1, males in Table 3 and females in
Table 5. Additionally, indirect effect results for the full model were listed in Table 2,
males in Table 4 and females in Table 6. The final sample for this model included 9,479
individuals.
In the pre-PTSD model, findings indicated that physiological responses were
partly associated with pre-disease biomarkers. The positive relationships were noted
among male participants, specifically between faster pulse rate and increased leukocyte
count (β = 0.509, p = 0.001), platelet count (β = 0.046, p = 0.019), and N/L ratio (β =
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0.506, p = 0.010). Higher systolic BP was also linked to increased platelet count (β =
0.074, p = 0.003). However, there was limited connection between physiological
responses and pre-disease markers among female participants. Only faster pulse rate
predicted elevated leukocyte count in this sample (β = 0.223, p = 0.046). In this case,
findings from male study participants yielded more similarities to the full model than the
female participants. Further, there was not any significant path found in male and female
models. Only a marginal effect of higher platelet count associated with PTSD diagnosis
in the male sample (β = 0.592, p = 0.064), and higher N/L ratio with PTSD diagnosis in
the female sample (β = 0.122, p = 0.058) were noted. Comparisons of relationships
between pre-disease biomarkers as predictors of the risk for being diagnosed with PTSD
suggest that findings in the male and female samples deviated from the full model. The
evidence from multiple group analysis of sex indicated some support for hypothesis 13A
that stated sex moderated the relationships in the pre-PTSD model.
Following PTSD diagnosis, both male and female participants showed different
physical responses. Among males, being diagnosed with PTSD was associated with
lower systolic BP (β = -0.044, p < 0.001), faster pulse rate (β = 0.060, p < 0.001), lower
N/L ratio (β = -0.211, p = 0.026), higher likelihood of being diagnosed with CVD (β =
0.109, p < 0.001) and sleep disorder (β = 0.133, p < 0.001). In comparison, females had
a significantly lower systolic BP (β = -0.052, p < 0.001), elevated platelet count (β =
0.014, p = 0.003), decreased N/L ratio (β = -0.145, p = 0.008) and enhanced the
likelihood of being diagnosed with CVD (β = 0.127, p < 0.001) and sleep disorder (β =
0.127, p < 0.001). The impact of PTSD on male participants and the full model showed
more similarity to both male and female participants. The evidence of PTSD impact
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provided minimal support to the differential impact of physiological responses, pre-
disease biomarkers, and pathology among males and females as stated in hypothesis 13A.
Results from the current study also revealed associations between physiological
response and pre-disease biomarkers in the aftermath of trauma. Among males, faster
pulse rate was found to be associated with higher leukocyte count (β = 0.207, p < 0.001)
and N/L ratio (β = 0.875, p = 0.002). In the same model, increased systolic BP predicted
higher platelet count (β = 0.057, p < 0.001), but lower N/L ratio (β = -0.998, p < 0.001).
Similarly, pulse rate was also associated with higher leukocyte count (β = 0.524, p
= .001), platelet count (β = 0.101, p = 0.008) and N/L ratio (β = 0.468, p = 0.002) among
females in the sample.
Further, associations between physiological responses and pre-disease biomarkers
with pathology were also evaluated. Lower diastolic BP (β = -0.154, p = 0.005) and pulse
rate (β = -0.269, p = 0.003) were found to significantly predicted CVD diagnosis among
male study participants. Only slower pulse rate marginally predicted higher risk of being
diagnosed with a sleep disorder (β = -0.130, p = 0.068) in the same sample. In
comparison, higher diastolic BP was the only significant predictor of pathology,
specifically sleep disorder (β = 0.091, p < 0.001) among female study participants.
Moreover, relationships between pre-disease biomarkers and pathology were also
identified. Lower platelet count (β = -0.468, p < 0.001) and higher N/L ratio (β = 0.146,
p < 0.001) were predictive of CVD diagnosis for males. In contrast, pre-disease
biomarkers had no direct association with pathology among women. In this case, findings
pertinent to physiological responses and pre-disease biomarkers as precursors for
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pathology from the full model shared more similar paths with male than among female
participants.
Indirect effects were also evaluated relative to sex. First, there was some evidence
that supported an indirect relationship between physiological responses and pathology
through pre-disease biomarkers. Systolic BP was indirectly related to risk of CVD among
male participants (β = -0.171, p < 0.001) through platelet count (β = -0.027, p = 0.002)
and N/L ratio (β = - 0.146, p < 0.001). Pulse rate also indirectly predicted the risk of
being diagnosed with CVD among male study participants (β = 0.018, p = 0.009). The
specific indirect effect through N/L ratio only had a marginal effect (β = 0.128, p =
0.003). Systolic BP was also indirectly related to the risk of being diagnosed with sleep
disorder (β = -0.048, p = 0.023), only marginally mediated by N/L ratio (β = -0.042, p =
0.051). There were no significant total and specific indirect effects found between
physiological responses and pathology in female participants. The findings from male
study participants indicated more similarities to the full model compared to female study
participants.
PTSD also indirectly associated with pre-disease biomarkers through
physiological responses. In male study participants, being diagnosed with PTSD was
linked to all three pre-disease biomarkers; leukocyte count (β = 0.017, p < 0.001)
significantly mediated by pulse rate (β = 0.012, p = 0.003), N/L ratio (β = 0.094, p <
0.001) through diastolic BP (β = 0.044, p = 0.001) and pulse rate (β = 0.052, p = 0.006).
Additionally, a specific indirect effect was also noted for PTSD and platelet count
mediated by diastolic BP (β = -0.002, p = 0.001). In comparison, PTSD indirectly
associated with leukocyte (β = 0.016, p = 0.029), and N/L ratio (β = 0.032, p = 0.030) in
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female study participants. There was only a marginal specific indirect effect identified
that connected PTSD and N/L ratio through diastolic BP (β = 0.022, p = 0.051)
The examination of indirect model also yielded relationships between PTSD and
pathology. PTSD showed significant indirect association to CVD (β = -0.034, p = 0.022).
The link was associated through several mediators including pulse rate (β = -0.016, p =
0.008), N/L ratio (β = -0.031, p = 0.018), diastolic BP and platelet count (β = 0.001, p =
0.008), diastolic BP and N/L ratio (β = 0.006, p = 0.001), as well as pulse rate and N/L
ratio (β = 0.008, p = 0.009). There were no significant total or specific indirect effects
linking PTSD and sleep disorder for male study participants. On the other hand, only a
total indirect effect was found to be significant between PTSD and CVD (β = -0.003, p =
0.048). Overall, the indirect model of male participants yielded more similarities to the
full model than female participants. These findings suggest that the proposed indirect
associations between physiological responses and pathology better fit male study
participants. It is possible that females have different indirect mechanisms linking PTSD
and pathology.
Race
Multiple group path analyses were also conducted to compare the full model and
racial groups (see Figures 6 and 7). In the current study, the racial group was separated
into two, a sample of white and non-white individuals. The direct effects for the white
sample were reported in Table 7 and the non-white sample in Table 9. The indirect
effects for the white sample are listed in Table 8 and the non-white sample in Table 10.
The sample for this analysis included 9,090 individuals.
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There was some evidence of moderation in relationships between physiological
stress response and pre-disease biomarkers in the pre-PTSD model, providing support to
hypothesis 13B. Faster pulse rate was associated with elevated platelet count (β = 0.345,
p = 0.006) among white study participants. A similar trend also applied to systolic BP
and platelet count (β = 0.051, p = 0.018). In comparison, non-white study participants
who maintained lower systolic BP (β = -0.436, p = 0.012) and higher pulse rate (β =
0.362, p = 0.048) reported higher N/L ratio. The findings from white study participants
yielded more similarities with the full model. Evidence of an association between pre-
disease biomarkers and the risk for a PTSD diagnosis also existed in the model. Higher
leukocyte count was found to be associated with higher likelihood of receiving PTSD
diagnosis among both white (β = 0.222, p = 0.025) and non-white (β = 0.379, p < 0.001)
study participants. This finding supports the second hypothesis that stated elevated pre-
disease biomarker will mark higher risk to being diagnosed with PTSD. Additionally,
non-white study participants with lower N/L ratio also reported higher risk for PTSD (β =
-0.214, p = 0.003). Findings on lower pre-disease markers were exclusive to the full
model and non-white study participants, which may imply blunted stress response due to
pre-existing allostatic loads.
In both groups, PTSD influenced the physiological response, pre-disease
biomarkers, and pathology in the aftermath of trauma. White study participants with
PTSD diagnosis had lower systolic BP (β = -0.039, p < 0.001), higher pulse rate (β =
0.028, p = 0.004), and marginally lower N/L ratio (β = -0.117, p = 0.050). On the other
hand, non-white study participants with PTSD only had lower systolic BP (β = -0.029, p
= 0.017). No connection between PTSD and pre-disease biomarkers was found in the
54
non-white study participants. PTSD also significantly enhanced the likelihood of being
diagnosed with CVD (βCVD white = 0.088, p < 0.001; βCVD non-white= 0.065, p < 0.001), and
sleep disorder (βsleep white = 0.125, p < 0.001; βsleep non-white = 0.130, p < 0.001) for both
groups. This evidence conveys more similarities for PTSD impacts between findings
from the full model and white study participants. White study participants appeared to
experience more alterations following PTSD diagnosis, which offers support to the
previous findings that non-white individuals have higher pre-existing allostatic load.
Despite the different impacts on physiological responses and pre-disease biomarkers,
those with a PTSD diagnosis from the full model, white and non-white study participants
were consistently found to have elevated risk for disease pathology. The findings further
suggested higher risk for pathology for non-white individuals. Taken together, these
findings may offer insights into various mechanism linking PTSD to pathology, yet it
yielded similar final adverse outcomes.
The model was evaluated by race to identify potential mechanisms of pathology
development. Following the PTSD diagnosis, white study participants who maintained
faster pulse rate also had higher leukocyte count (β = 0.307, p = 0.001), platelet counts (β
= 0.040, p = 0.006), and N/L ratio (β = 0.659, p = 0.001). In the same group, those with
higher systolic BP reported higher platelet count (β = 0.044, p = 0.002). Non-white study
participants with higher pulse rate also reported elevation in leukocyte count (β = 0.413, p
< 0.001), and N/L ratio (β = 0.510, p = 0.001). Increases in diastolic BP also associated
with higher N/L ratio (β = 0.740, p = 0.046). Interestingly, elevated systolic BP was
associated with decreased N/L ratio in both groups (βwhite = -0.725, p < 0.001; βnon-white =
-1.015, p = 0.023). Results from white study participants indicate closer similarities with
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the full model suggesting race had a moderating effect on the relationship between
physiological responses and pre-disease biomarkers in the aftermath of a PTSD diagnosis.
The model also indicated evidence of significant paths that connect physiological
responses and pathology for both groups.
White study participants with lower diastolic BP (β = -0.070, p = 0.005) and
pulse rate (β = -0.090, p = 0.015) were at elevated risk for being diagnosed with CVD. In
comparison, findings from non-white study participants indicated lower pulse rate
significantly associated with sleep disorder (β = -0.117, p = 0.025). In this case, results
on the relationship between physiological responses and pathology from non-white
individuals illustrated similar paths with the full model. These findings also indicated that
race moderated the relationship between the two. Moreover, evidence also provided
support for pre-disease biomarkers as a precursor to disease pathology. Lower platelet
count was significantly associated with the higher likelihood of being diagnosed with
CVD (β = -0.465, p < 0.001) for white participants. The opposite effect was found for
N/L ratio which was associated with higher risk of CVD (β = 0.041, p = 0.005).
Additionally, lower platelet counts significantly predicted sleep disorder (β = -0.141, p =
0.020). On the contrary, there was no evidence of pre-disease biomarkers as predictors
for pathology in non-white study participants. The paths that connected pre-disease
biomarkers and pathology in the full model displayed more similarities with white study
participants. It further suggested mechanisms of pathology development may be
moderated by race as each group may experience different challenges relevant to their
psychological trauma.
56
Indirect effects were also evaluated to compare the white and non-white study
participants relevant to physiological functions following PTSD diagnosis. Results
yielded indirect relationship between physiological responses and pathology limited to
white study participants. Systolic BP significantly predicted CVD (β = -0.051, p < 0.001),
specifically through platelet (β = -0.020, p = 0.006), and N/L ratio (β = -0.029, p =
0.008). Systolic BP also indirectly associated with sleep disorder (β = -0.017, p = 0.022)
mediated by platelet (β = -0.006, p = 0.046). Additionally, some specific indirect effects
also supported this notion. Pulse rate was associated with CVD through platelet (β = -
0.019, p = 0.006) and N/L ratio (β = 0.027, p = 0.014). There was no significant total or
specific indirect effect between physiological responses and pathology in the sample of
non-white study participants. It appears that the indirect associations between
physiological responses and pathology found in the white study participants shared
commonalities with the full model. The absence of indirect effect in non-white
individuals suggested potentially distinct mechanism compared to the white individuals
and the full model.
Result on indirect effects also illustrated the relationship between PTSD and pre-
disease biomarkers through physiological responses in both white and non-white
participant groups. Among white study participants, a total indirect effect between PTSD
and leukocyte was noted (β = 0.011, p = 0.006). The indirect path was significantly
mediated by pulse rate (β = 0.009, p = 0.020). There were also additionally two specific
indirect paths identified; PTSD and platelet count through diastolic BP (β = -0.002, p =
0.005) and pulse rate (β = 0.001, p = 0.031). In non-white study participants, being
diagnosed with PTSD was indirectly associated with leukocyte count (β = 0.014, p =
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0.047), without any significant specific indirect path. Results yielded from both white
study participant groups displayed more similarities to the full model. These findings
may suggest that indirect connections between PTSD and pre-disease biomarkers are
moderated by race.
Further, in the sample of white study participants, PTSD was found to be
associated with pathology through physiological responses and pre-disease biomarkers.
PTSD was found to be indirectly associated to CVD by diastolic BP and platelet (β =
0.001, p = 0.011), pulse rate and platelet count (β = -0.001, p = 0.031), as well as
diastolic BP and N/L ratio (β = 0.001, p = 0.015). In comparison, only a marginal specific
indirect effect was found between PTSD and sleep disorder mediated by diastolic BP and
platelet count (β = 0.000, p = 0.058). There were not any total and specific indirect
effects found in non-white study participants. Both findings from white and non-white
study participants displayed deviation from the full model. This may suggest unique
indirect mechanism between PTSD and pathology relevant to experiences unique to each
racial group. Overall, the findings from race multiple group path analysis provided some
support for the proposed model. White study participants displayed more similar paths to
the full model. When examining non-white study participants, one may need to be
cautious as different challenges associated with the traumatic experience could alter
physiological responses and outcomes.
Age
Comparison between age groups were also explored. Age was separated in three
groups: 0-17 years of age (children), 18-49 years (adults), and 50 years of age and older
(older adults). The sample included 18,242 individuals. The direct and indirect findings
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from child study participants listed in Tables 11 and 12, respectively. Table 13 showed
direct effects and Table 14 displayed indirect effects from adult study participants. Tables
15 and 16 indicated direct and indirect effects from older adult study participants.
Additionally, Figures 8, 9 and 10 displayed path models for the three age groups.
The connection between physiological responses and pre-disease biomarkers in the
pre-PTSD model indicated some significant findings. In the child sample, it was noted
that increased systolic BP was related to lower leukocyte count (β = -1.155, p < 0.001).
When children experienced increased pulse rate, it was followed with decreased platelet
count (β = -0.114, p = 0.015). Evidence for associations between physiological responses
and pre-disease biomarkers were also found in adult participants. Faster pulse rate was
associated with elevated leukocyte count (β = 0.310, p = 0.004). Increased systolic BP
was also found to be associated with elevated platelet count (β = 0.066, p = 0.005).
Additionally, higher diastolic BP was associated with a decrease of N/L ratio (β = -0.550,
p = 0.015). There was only a significant path between physiological responses and pre-
disease biomarkers in older adult participants; higher systolic BP was related to higher
platelet count (β = 0.066, p = 0.032). In the pre-PTSD model, evidence also provided
support that pre-disease biomarkers predicted the risk of PTSD limited to adult and older
adult groups. Elevated leukocyte count (β = 0.487, p < 0.001) and lower N/L ratio (β = -
0.396, p = 0.009) indicated enhanced risk of being diagnosed with PTSD in the adult
sample. In comparison, elevated N/L ratio was associated with the risk of PTSD in the
older adult sample (β = 0.515, p < 0.001). Results discovered more similar paths between
the full model and the adult group in the pre-PTSD model. Taken together, documented
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evidence may provide insights into the role of age in understanding the physiological
profile relevant to risk for PTSD.
PTSD effect on physiological responses, pre-disease biomarkers, and pathology
seemed to be exclusive to selected groups. Children who were diagnosed with PTSD had
significantly lower systolic BP (β = -0.040, p = 0.001) and pulse rate (β = -0.171, p <
0.001). They also experienced an increase in diastolic BP (β = 0.030, p = 0.002). In
comparison, PTSD increased pulse in adults (β = 0.026, p = 0.025) and reduced systolic
BP in older adult participants (β = -0.061, p < 0.001). The impact of PTSD on pre-disease
biomarkers was only noted in older adult participants. Specifically, PTSD was associated
with lowered platelet count (β = -0.011, p = 0.038). Further, there was no evidence for the
connection between PTSD and pathology in the child sample. However, enhanced risk of
pathology was noted among adult and older adult study participants. PTSD was linked to
CVD (βadult = 0.029, p < 0.001; βolderadult = 0.194, p < 0.001) and sleep disorder (βadult =
0.107, p < 0.001; βolderadult = 0.138, p < 0.001) in both adult and older adult study
participants. Overall, the findings from adult and older adult participants revealed more
common paths with the full model. Evidence indicated the role of age in moderating the
impacts of PTSD.
The proposed model further investigated the potential role of age moderating the
relationships between physiological responses, pre-disease biomarkers, and pathology.
The result yielded significant connections between physiological responses and pre-
disease biomarkers in the post-PTSD model exclusive to adult and older adult groups. In
adult sample, faster pulse rate was linked to elevated leukocyte count (β = 0.236, p <
0.001), platelet count (β = 0.029, p = 0.006), and N/L ratio (β = 0.223, p = 0.002). Higher
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systolic BP also predicted an increase in platelet count (β = 0.034, p = 0.043) and had an
opposite effect in N/L ratio (β = -0.249, p = 0.017). In comparison, faster pulse rate was
related to lower platelet count (β = -0.080, p = 0.049), whereas higher systolic BP linked
to lower N/L ratio (β = -1.807, p < 0.001) in the older adult group. Compared to the full
model, findings from the samples of adult participants indicate more similar paths of
physiological responses and pre-disease biomarkers. This may suggest potential
maturation and aging effects to physiological response and pre-disease biomarkers that
resulted in different responses following PTSD.
The model also examined relationships between physiological responses and pre-
disease biomarkers as precursors for pathology, exclusive to the older adult group. There
was not any significant path indicated in children and adult study participants. It was
noted that lower systolic BP (β = -0.615, p < 0.001) and pulse rate (β = -0.694, p < 0.001)
related to an enhanced risk for CVD in older adult study participants. Lower systolic BP
(β = -0.114, p = 0.002), pulse rate (β = -0.108, p = 0.001) and higher diastolic BP (β =
0.090, p = 0.008) were found as precursors for sleep disorder in the same sample.
Relevant to pre-disease biomarkers as precursors of pathology, it was noted that elevated
leukocyte count (βCVD = 0.245, p = 0.000; βsleep = 0.057, p = 0.002), lower platelet count
(βCVD = -1.471, p < 0.001; βSleep = -0.406, p < 0.001) and N/L ratio (βCVD= -0.189, p <
0.001; βSleep = -0.018, p = 0.012) linked to the risk for both CVD and sleep disorder in the
older adult sample. Comparison of findings from all three groups suggested that the older
adults resembled most similar paths to the full model.
The indirect effects were also examined across all three age groups; children,
adult and older adult group. The connection between physiological responses and
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pathology was limited to older adult study participants. Systolic BP was indirectly linked
to CVD (β = 0.318, p < 0.001), significantly mediated by leukocyte count (β = -0.028, p
= 0.044) and N/L ratio (β = 0.342, p < 0.001). Additionally, four total indirect effects
were also noted; diastolic BP to CVD (β = 0.186, p = 0.012), pulse rate to CVD (β =
0.228, p = 0.004), diastolic BP to sleep disorder (β = -0.026, p = 0.014), and pulse rate to
sleep disorder (β = 0.050, p < 0.001). There was not any specific indirect effects
associated with these significant paths. Further, indirect associations between PTSD and
pre-disease biomarkers were evident in adult and older adult participants. There was only
one total indirect effect between PTSD and N/L ratio (β = 0.010, p = 0.014) in adult
participants. On the other hand, PTSD diagnosis predicted leukocyte count (β = 0.013, p
= 0.021) as well as PTSD and N/L ratio (β = 0.104, p = 0.013) mediated by diastolic BP
(β = 0.111, p = 0.003) in older adult participants. Finally, indirect relationships between
PTSD and pathology were only evident in older adult groups. There were four specific
indirect effects noted; PTSD and CVD mediated by diastolic BP (β = 0.038, p < 0.001),
PTSD and CVD mediated by diastolic NL and N/L ratio (β = -0.021, p = 0.001), PTSD
and sleep disorder mediated by diastolic BP (β = 0.007, p = 0.005), and PTSD and sleep
disorder mediated by diastolic BP and N/L ratio (β = -0.002, p = 0.031). The evaluation
of indirect findings indicated most similarities between the full model and older adult
participants, which may suggest distinct physiological processes associated with different
aging state.
Body Mass Index (BMI)
Multiple group path analysis also explored the role of BMI in influencing the
relationship between psychological trauma, physiological responses, pre-disease
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biomarkers, and pathology. The sample size for this analysis was 2,155. BMI were
categorized into two groups: lower and higher BMI. Lower BMI group included those
with BMI between 0-25. The higher BMI group included individuals with BMI of 25 and
larger. Direct effects for lower BMI group were listed in Table 17, and Table 19 for
higher BMI group. Indirect effects were showed in Tables 18 and 20 for lower and higher
BMI groups, respectively. Additionally, Figures 11 and 12 displayed the path models for
both groups. Further description of each model is provided below.
In pre-PTSD model, there was evidence of connection between physiological
responses and pre-disease biomarkers specific to participants exclusive to higher BMI.
Those with faster pulse rate were found to have higher leukocyte count (β = 0.271, p =
0.020). Increases in systolic BP also predicted higher platelet count (β = 0.069, p = 0.005).
Similar patterns were also found in the connection between pre-disease biomarkers and
the risk of being diagnosed with PTSD as there was no significant path found in the lower
BMI group. However, decreases in N/L ratio indicated higher risk in being diagnosed
with PTSD (β = -0.191, p < 0.001) noted in the higher BMI group. Findings in the higher
BMI group indicate more similar paths to the full model compared to the lower BMI
group. These findings indicate different physiological mechanisms between lower and
higher BMI groups, which support potential moderation effects of BMI.
Further, the post-PTSD model indicated some physical health impacts. PTSD did
not appear to affect physiological responses and pre-disease biomarkers in individuals
with lower BMI. However, in this group there was evidence of relationship between
PTSD and pathology, specifically sleep disorder (β = 0.109, p < 0.001). The analysis also
revealed individuals with higher BMI and diagnosed with PTSD had lower systolic BP (β
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= -0.031, p = 0.036) and higher risk of being diagnosed with sleep disorder (β = 0.037, p
= 0.048). There was no connection between PTSD and pre-disease biomarkers in this
group. The impacts of PTSD showed minimal support in the full model. The only
consistent evidence throughout the full model for lower and higher BMI was the
association between PTSD and pathology, which may suggest similar outcomes but
through distinct processes.
The model also revealed some relationships between physiological responses and
pre-disease biomarkers. In the lower BMI group, a positive association was noted
between pulse rate and leukocyte count (β = 0.374, p = 0.021). Higher systolic BP (β =
0.094, p = 0.024) and pulse rate (β = 0.073, p = 0.025) were associated with elevated
platelet count in the same group. Lower systolic BP was found to be associated with
higher N/L ratio (β = -2.277, p = 0.031). On the contrary, a negative relationship was
found between systolic BP and platelet count (β = 0.085, p = 0.002) in the higher BMI
group. Higher systolic BP (β = -0.871, p = 0.049) also linked to lower N/L ratio in the
same group. Both low and high BMI groups shared some similar paths with the full
model, yet there were some distinct paths as well, possibly representing different
physiological processes.
Investigations were extended to the relationship between physiological responses
and pre-disease biomarkers as precursors for pathology. Individuals with lower BMI and
elevated systolic BP were shown to have higher risk of being diagnosed with CVD (β =
0.158, p = 0.045). In comparison, elevated diastolic BP was the only physiological
response precursor that predicted the risk of being diagnosed with sleep disorder (β =
0.150, p = 0.024) in the sample of participants with higher BMI. Additionally, pre-
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disease biomarkers also related to the risk of pathology. In the sample of individuals with
lower BMI, elevated N/L ratio was associated with higher risk for CVD diagnosis (β =
0.040, p = 0.001). Depleted platelet count was linked to sleep disorder diagnosis (β = -
0.251, p = 0.012) in the same sample. In the higher BMI group, higher platelet predicted
CVD (β = -0.815, p < 0.001), whereas lower platelet count was linked to sleep disorder (β
= -0.396, p = 0.006). Taken together, these findings suggest some similarities between
each group and the full model. Nevertheless, distinct paths were also noted across the two
groups, implying potential moderation effects of BMI in physiological functions.
The currents study also evaluated the indirect effects in a post-PTSD model.
There was no significant total and specific indirect effect in the lower BMI group. On the
other hand, there was a few significant total indirect effects in the higher BMI group.
Systolic BP was indirectly associated with the diagnosis of CVD (β = -0.0110, p = 0.011).
A specific path indicated that the association was only significant through platelet count
(β = -0.069, p = 0.019). A specific path that connected systolic BP and sleep disorder
through platelet (β = -0.034, p = 0.036) was also noted. The findings from the evaluation





The current study focused on the interplay between physiological functions and
relevant risks for PTSD and pathology in the context of military families. To date,
research has documented adverse physical health consequences and potential spillover
effects related to PTSD in the military population (Paulus et al., 2013; Lindqvist et al.,
2014; Beristianos et al., 2016; Williams et al., 2015; Allen et al., 2018; Lester et al.,
2010). However, there are limited studies exploring the underlying connection between
the two. The current section provides summary of the findings and further explore the
explanation behind them.
In the pre-PTSD model, as expected, a faster pulse rate and higher leukocyte
count was linked to an enhanced risk of being diagnosed with PTSD. Alterations in
physiological responses and pre-disease biomarkers support the concept of allostatic
mechanism responses to environmental demands (McEwen, 1998). Abboud and Singh
(2017) provide an example of the connection between physiological responses and pre-
disease biomarkers. In a case of hypertension, high blood pressure may damage the blood
vessel wall, sending signals to start the immune response (Abboud & Singh, 2017).
Therefore, the combination of both physiological responses and pre-disease biomarkers
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provide insights into the physiological profile and mechanisms that can be used to
assess the risk for PTSD.
To date, several studies have explored the physiological profile relevant to the
risk for PTSD. Sumner and colleagues (2019) highlighted a potential bidirectional
relationship between PTSD and inflammation and suggested the idea of certain
physiological measures as an alternative to assess risks for PTSD. Longstanding evidence
of increased inflammation in the aftermath of trauma has been documented (Sumner et al.,
2019; Lindqvist et al., 2017). On the other hand, Sumner and colleagues (2019) discussed
the potential role of existing inflammation in altering one's response to a threat which
then could increase the subsequent risk of developing PTSD (Sumner et al., 2019). Pre-
existing inflammation can influence amygdala functions that are essentials for memory
and learning which are key components for PTSD development. A study discovered
greater amygdala responses relevant to those with higher inflammation (Muscatell et al.,
2015). Overactivity in the amygdala has been linked to various problems including
emotional regulations which can enhance the risk for PTSD, as it limits one’s ability to
cope with trauma. These findings suggest that individuals with a higher level of
inflammation may also be at a higher risk for developing PTSD following psychological
trauma. Physiological profiles can be used to identify individuals who are at higher risks
for PTSD and physical health problems.
The current study also documents mixed impacts of PTSD on different
physiological aspects and pathology. Being diagnosed with PTSD has mixed effects on
physiological responses. These findings are partially consistent with Buckley and
colleagues (2008) who documented evidence of higher blood pressure and pulse rate
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among those with PTSD diagnoses. Interestingly, individuals with PTSD diagnoses
reported lower pre-disease biomarkers. A previous study indicated the opposite impact of
PTSD on inflammatory responses marked by a higher count of leukocytes and platelet
counts (Lindqvist et al., 2017). However, different studies suggest a blunted stress
response following early trauma exposure (Lovallo et al., 2012). As the stress response
system overloads, the ability to identify threats decrease. Thus, the lower pre-disease
biomarkers responses may indicate an overloaded system. PTSD was directly linked to
enhanced risks for pathology which is consistent with results in previous research. A
recent study highlighted elevated incident risks for cardiovascular disease in aging
veterans with PTSD (Beristianos et al., 2016). Similarly, PTSD is also associated with
several sleep disorders (Williams et al., 2015). Finally, there was evidence of comorbidity
between cardiovascular disease and sleep disorders. One article documented evidence of
comorbidity between insomnia and cardiovascular disease, potentially due to
dysregulation of the HPA, which affects inflammation (Javaheri & Redline, 2017).
Despite accumulated studies documenting alteration in physical functions
following PTSD, there are limited studies exploring the underlying connection between
various physiological alterations following PTSD. In the current study, the evidence
provided supports for all three proposed direct and indirect paths that connect
physiological functions, pre-disease biomarkers, and pathology illuminate insights into
the mechanism between PTSD and pathology.
Multiple group analysis
The current study also investigated multiple group analyses based on several
demographic characteristics in addition to the full model and how they influence
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physiological functions. The characteristics include sex, race, age, and BMI. Further
discussion of each model is provided below.
Sex
A comparison of male and female study participants provided support for sex as a
moderator for the relationships between PTSD and physical functions. There were more
similarities between male study participants and the full model then between female
study participants and the full model, which may suggest that PTSD impacts
physiological functions of female study participants distinctively. Thus, the current model
provides the best insights limited to male study participants. Further investigations of the
underlying mechanism for females are needed.
A higher prevalence of PTSD in females compared to their male counterparts was
found (Breslau, 2009; Olff, 2017), which supports the notion of sex difference in PTSD.
Further, different studies also documented different symptoms presented by males and
females. Males reported more impulsivity following PTSD diagnoses (Pineless et al.,
2017). On the other hand, females displayed self-blame as a form of cognitive symptoms
(Pineless et al., 2017). Another study reported that numbing symptoms are more
prevalent among male active-duty military, while female experienced avoidance, numb,
and hyperarousal, but not hypervigilance (Hourani et al., 2015). The differential risk and
presentation raise the question of the need for a distinct diagnosis due to the
heterogeneity of presentation of PTSD across sex groups.
The difference in prevalence and symptom presentation may be explained by
different factors that influence outcomes following trauma, including factors that shape
the traumatic experience as well as risk or protective factors. The mechanisms of stress
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response system have been found to work differently between males and females. Animal
studies have documented evidence of differential responses to stress. Sexual dimorphism
was indicated in fear learning, as male and female rats displayed different behaviors
(Pooley et al., 2018). Male rats displayed startle responses following a stressor,
meanwhile female rats did not display similar responses (Pooley et al., 2018). These
results raise the question of whether males and females perceive stress differently.
Something that is perceived as a threat for males may not be perceived as a threat for
females.
Race
The investigation also investigated the relationship between the full model, white,
and non-white study participants. Results support differential responses and risks relevant
to PTSD and physiological functions. White study participants shared more similar paths
with the full model. Therefore, the mechanisms that connects PTSD and physiological
function remain elusive. Exploration of different physiological functions are needed to
understand the extent of damages relevant to PTSD in non-white study participants.
Race serves as a moderator for relationships between stress and health.
Accumulated evidence indicates worse health outcomes among non-white individuals.
Duru and colleagues (2012) found that non-white individuals have a higher level of stress
that is associated with an elevated risk of mortality. Further, a study by Ferguson and
colleagues (2013) detected lowered inflammation in African American individuals,
suggesting a potential blunted stress response. Race serves as a proxy beyond group
membership. It also provides insights into potential socioeconomic status such as
additional stressors unique to a specific race group. This evidence provides support for
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Cumulative Advantage/Disadvantage Theory. This theory explains the systemic
cumulative gains/losses associated with certain characteristics (e.g., race). In other words,
being non-white individuals are associated with certain benefits or challenges. In this
case, experiencing racism or poverty may attribute additional stressors following
psychological trauma, which then could contribute to a higher risk for PTSD.
Data on race unfolds information beyond affiliation to certain groups or cultures.
It further provides information on challenges as well as resources that are unique to a
group. Comparisons of race discover different relationships between PTSD and
physiological functions. The absence of significant paths in non-white individuals
especially elucidates deviation from the proposed model, which maintains elevated risks
for non-white individuals as intervention remains unprecedented. Further exploration of
different physiological functions are needed to gain insight on the mechanisms that fit
non-white individuals.
Age
Comparisons of age groups indicated the effect of moderation, suggesting
differential risks for PTSD and physical health problems. Findings on children provided
minimal support to the proposed model. On the other hand, older adult study participants
displayed most shared paths with the full model which also implies most vulnerability
were from the effects of PTSD. These findings raise questions on different mechanisms
for children and adults.
Differential risks across age groups may be explained by select biological factors,
such as the maturation of the stress response system. The limbic system serves as the
central processing for stress, as it appraises the situation prior to sending out a signal to
71
start a chain of reactions (Canteras et al., 2020). In children, this area is not fully
developed yet. Therefore, they may perceive a threat differently, which then influences
responses produced by this particular age group that may differ from older individuals. In
comparison, older adults were reported to have distinct cortisol production patterns as
well as limbic system structure (Ennis et al., 2019). This finding suggests that the aging
process intervenes with the alteration in stress response system activity and structure.
Further, the accumulation of stress also has implications on the functions of the
stress response system. Crimmins and colleagues (2003) indicated that the allostatic load
accumulation did not become significant prior to the age of twenty and exponentially
worsened as people continued to age up to sixty, where it stabilized. Exposure to stress in
children appears to link to allostasis but not allostatic load. On the other hand, older
adults have an accumulation of allostasis that may create allostatic load or overload. Due
to their higher allostatic load or overload, worse health outcomes are expected out of this
group. These results provide further support for the allostatic load model and its
contribution to pathology development (McEwen, 1998).
Body Mass Index (BMI)
BMI has been documented as a proxy of health status as it is highly correlated
with different health outcomes, including morbidity and mortality (Abdelaal et al., 2017),
and quality of life (Korhonen et al, 2014). In the current study, BMI was investigated as a
moderator of psychological trauma and physical function relationships, however, little
evidence about this was available.
As the current model fails to capture the physiological alterations following PTSD
relevant to BMI, existing studies provide evidence of the impacts of BMI on different
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physiological functions. Wester and colleagues (2014) observed a higher level of cortisol
among obese individuals compared to their non-obese counterparts. A prolonged elevated
level of cortisol means a high-level activity of the stress response system which can
increase the risk for various mental health symptoms including depression (Santen et al.,
2011). Interestingly, a study on PTSD indicated that opposite patterns of low cortisol
levels were linked to a higher vulnerability for this specific mental health diagnosis
(Mouthaan et al., 2014). This raises a question on whether cortisol level provides a
protective mechanism for PTSD among those with higher BMI. Additionally, Choi and
colleagues (2013) also observed elevated C-reactive proteins, a marker of inflammation,
among individuals with high BMI. These findings provide insights that BMI may
moderate PTSD impacts on physiological functions beyond the current model.
In addition to potentially serving as a mediator between PTSD and physiological
responses, evidence also suggests change in BMI as a trauma response (Kubzansky et al.,
2014). Similar finding was also noted by Smith and colleagues (2015). Moreover,
LeardMann and colleagues (2015) observed both increase and decrease of BMI following
PTSD. This finding suggests potential bidirectional impacts of PTSD on BMI. The
alterations in behavioral responses, including eating and physical inactivity as a form of
coping with the symptoms of PTSD. Therefore, these types of behaviors are relevant and
need to be considered in future diagnosis process of PTSD.
Model comparisons
Throughout the entire model, heterogeneity of the physiological responses and
pre-disease biomarkers were noted in pre-and post-PTSD models. Previous literature has
documented mixed findings in this area. Several studies noted accelerated responses such
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as elevated leukocyte levels and increased heart rate (Buckley et al., 2004) and elevated
inflammatory responses (Lindqvist et al., 2017). However, d’Andrea and colleagues
(2013) noted mixed findings. In addition to acceleration in heart rate and skin
conductance responses, they also observed deceleration on the same measures. Further
examination of the sub-samples indicated that those who experienced moderate exposure
to trauma and exhibited moderate symptoms of PTSD reported acceleration responses.
On the contrary, those with extreme trauma exposure and PTSD symptoms displayed
decelerated responses, which suggest blunted stress responses (d’Andrea et al., 2013).
Deriving from this finding, individuals with higher exposure to trauma may also have
higher allostatic load accumulation. Incorporating information relevant to the traumatic
experience and pre-existing allostatic load can provide better insight into the expected
outcome. This also highlighted the importance of not overlooking different responses to
PTSD as decelerated responses still tell a story relevant to the psychological trauma.
Despite the various paths between the variables, evidence of the relationships between
PTSD and pathology were observed across models. This finding confirms evidence from
previous works (Beristianos et al., 2016). The homogeneity of pathology outcomes
suggests equifinality of PTSD. PTSD may affect physiological functions unique to each
individual. However, once the alterations reach a certain threshold, they may contribute
to pathology development. Explorations of PTSD effects across different physiological
functions are important to advance the understanding of diverse pathology development
mechanisms.
Findings from the current study also suggest that the data support the full model.
However, comparisons of sub-samples suggested otherwise. This implies that although
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the current proposed model provides insights on a mechanism that connects PTSD,
physiological functions, and pathology, the model is not inclusive for all individuals. In
the case of race analysis, for example, most participants were white. Thus, it may provide
limited insights into the mechanism in non-white individuals. Further explorations of
various mechanisms are needed to develop inclusive and comprehensive physiological




Overall, the current study identifies physiological profiles of individuals who are
at a higher risk for PTSD and for higher impacts following PTSD. Pulse rate and
leukocyte counts are relevant measures for the risk of PTSD, while pulse rate and N/L
ratios following PTSD diagnoses serve as precursors for pathology development.
Evidence of pathology as adverse health outcomes are also established. The results also
provide insights into a mechanism that connects PTSD and pathology. However, it is
worth mentioning that the model comparisons indicate limitations in capturing
mechanisms of PTSD and physiological functions in select groups. Nevertheless, these
results can be utilized as a monitoring framework. Finally, based on multiple group
analyses, females, non-white, and older adults were at higher risk for adverse physical
health impacts following PTSD diagnoses.
Implications
The current study advances our understanding of the relationship between mental
and physical health. Understanding the interconnection between the two should be used
to encourage movement between research in physical and mental health services into less
binary areas as the two are highly interconnected. Advancement in the science of PTSD
can also be further used to design evidence-based prevention and intervention efforts to
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minimize the adverse health outcomes from PTSD. Mental health screening is the
first step needed to be taken to identify stressors, symptoms, risks or protective factors,
and allostatic load. This information can then be utilized to develop a profile relevant to
risks for mental disorders or physical health issues. Routine monitoring should be
implemented for those with high-risk physiological profiles. The physiological profile
can also be used to design a personalized treatment plan that can potentially have higher
effectiveness, as it addresses the specific problems and needs of patients.
Limitations
The nature of the secondary data utilized for the current study contributes to
several limitations. First, the current data focuses on objective physiological measures.
Although it provides insights into physical health, it fails to capture the subjective
components of trauma experience. Secondly, the data was collected from EHR, which
means that data is only available when participants visited the CERNER-associated
clinics. It inadequately encapsulates information in-between visits or when participants
visit healthcare facilities outside the system. Additionally, there were relevant concerns
about the consistency of the data collection process as it was done by different health
professionals. Further, the identification for military status came from the type of
insurance utilized to access healthcare. Unfortunately, it is impossible to identify those
with active military status, veterans, or spouses due to HIPPA. Finally, psychological
trauma was identified using ICD code for PTSD diagnosis. Limited information on




Aside from the current limitations, this study contributes to the advancement of
knowledge relevant to the interplay between PTSD and physiological functions.
Examinations of different physical functions (e.g., cortisol levels) and pathology (e.g.,
autoimmune disorder) may expand our understanding of mechanisms between PTSD and
physical health. Future studies will also need to include primary data collection so
researchers can identify the military status (e.g., active, veteran, spouse). This will allow
us to understand the magnitude of the impacts of trauma for each group. Additionally, an
assessment of subjective experiences, including the type of stressor participants are
facing, and other psychosocial resources, will enrich our understanding of psychological
trauma in the context of military families.
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Direct effects for full model
Predictors Outcomes β P-value
Systolic BP Pre Leukocyte Pre -0.006 0.936
Diastolic BP Pre -0.106 0.128
Pulse Pre 0.293 0.004*
Systolic BP Pre Platelet Pre 0.055 0.005*
Diastolic BP Pre -0.005 0.796
Pulse Pre 0.028 0.220
Systolic BP Pre N/L ratio Post -0.761 0.079
Diastolic BP Pre -0.343 0.026*
Pulse Pre 0.315 0.138
Leukocyte Pre PTSD 0.228 0.007*
Platelet Pre -0.338 0.279
N/L ratio Pre -0.143 0.064
PTSD
Systolic BP Post -0.034 0.000*
Diastolic BP Post 0.008 0.115
Pulse Post 0.029 0.000*
Systolic BP Post Leukocyte Post -0.086 0.035*
Diastolic BP Post -0.056 0.103
Pulse BP Post 0.330 0.000*
PTSD 0.003 0.832
Systolic BP Post Platelet Post 0.049 0.001*
Diastolic BP Post 0.008 0.413
Pulse Post 0.050 0.001*
PTSD -0.002 0.578
Systolic BP Post N/L ratio -0.757 0.000*
Diastolic BP Post 0.0221 0.122
Pulse Post 0.656 0.000*
PTSD -0.104 0.027*
Leukocyte Post CVD 0.008 0.330
Platelet Post -0.248 0.000*
N/L ratio Post 0.026 0.000*
PTSD 0.093 0.000*
Systolic BP Post -0.001 0.964
Diastolic BP Post -0.040 0.006*
Pulse Post -0.059 0.006*
Leukocyte Post Sleep disorder 0.002 0.842
Platelet Post -0.077 0.030*
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N/L ratio 0.008 0.150
PTSD 0.121 0.000*
Systolic BP Post -0.030 0.076
Diastolic BP Post 0.025 0.118
Pulse Post -0.033 0.054
CVD WITH SLEEP 0.009 0.000*
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Table 2
Indirect effects for Full Model
Predictors Outcomes β p-value
Total indirect
effect
Systolic BP post CVD -0.033 0.000*
Specific
indirect
Systolic BP post-leukocyte post-CVD -0.001 0.375
Systolic BP post-platelet post-CVD -0.012 0.002*
Systolic BP post-N/L ratio post-CVD -0.020 0.000*
Total indirect
effect
Diastolic BP post CVD 0.003 0.492
Specific
indirect
Diastolic BP post-leukocyte post-CVD 0.000 0.396
Diastolic BP post-platelet post-CVD -0.002 0.426
Diastolic BP post-N/L post-CVD 0.006 0.159
Total indirect
effect
Pulse post CVD 0.007 0.287
Specific
indirect
Pulse post-Leukocyte post-CVD 0.003 0.332
Pulse post- platelet post-CVD -0.013 0.001*
Pulse post-N/L post-CVD 0.017 0.000*
Total indirect
effect
PTSD CVD -0.003 0.096
PTSD-systolic BP post-CVD 0.000 0.241
PTSD-diastolic BP post-CVD 0.000 0.964
PTSD-pulse post-CVD -0.002 0.047*
PTSD-leukocyte post-CVD 0.000 0.839
PTSD-platelet post-CVD 0.000 0.586
PTSD-N/L post-CVD -0.003 0.022*
PTSD-systolic BP post-leukocyte post-CVD 0.000 0.460
PTSD- diastolic BP post-leukocyte post-CVD 0.000 0.380
PTSD-pulse post-leukocyte post-CVD 0.000 0.346
PTSD-systolic BP post-platelet post-CVD 0.000 0.487
PTSD-diastolic BP-platelet post-CVD 0.000 0.006*
PTSD-pulse post-platelet post-CVD 0.000 0.006*
PTSD-systolic BP post-N/L post-CVD 0.000 0.343
PTSD-diastolic BP post-N/L post-CVD 0.001 0.002*
PTSD-pulse post-N/L post-CVD 0.001 0.011*
Total indirect
effect
Systolic BP post Sleep disorder -0.010 0.030*
Specific
indirect
Systolic BP post-leukocyte post-sleep disorder 0.000 0.841
Systolic BP post-platelet post-sleep disorder -0.004 0.044*
Systolic BP post-N/L post-sleep disorder -0.006 0.132
Total effect Diastolic BP post Sleep disorder 0.001 0.506
Specific
indirect
Diastolic BP post-leukocyte post-sleep disorder 0.000 0.843
Diastolic BP post-platelet post-sleep disorder -0.001 0.465
Diastolic BP post-N/L post-sleep disorder 0.002 0.183
Total effect Pulse post Sleep disorder 0.002 0.732
Specific
indirect
Pulse post-leukocyte post-sleep disorder 0.001 0.842
Pulse post-platelet post-sleep disorder -0.004 0.042*
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Pulse post-N/L post-sleep disorder 0.005 0.175
Total effect PTSD Sleep disorder 0.000 0.976
PTSD-systolic BP-sleep disorder 0.000 0.373
PTSD-diastolic BP-sleep disorder 0.001 0.084
PTSD-pulse post-sleep disorder -0.001 0.104
PTSD-leukocyte post-sleep disorder 0.000 0.879
PTSD-platelet post-sleep disorder 0.000 0.583
PTSD-N/L post-sleep disorder -0.001 0.186
PTSD-systolic BP post-platelet post-sleep disorder 0.000 0.845
PTSD-Diastolic BP post-leukocyte post-sleep
disorder
0.000 0.841
PTSD-pulse post-leukocyte post-sleep disorder 0.000 0.842
PTSD-Systolic BP post-platelet post-sleep disorder 0.000 0.515
PTSD-Diastolic BP post-platelet post-sleep
disorder
0.000 0.055
PTSD-pulse post-platelet post-sleep disorder 0.000 0.068
PTSD-systolic BP post-N/L post-sleep disorder 0.000 0.351
PTSD-diastolic BP post-N/L post-sleep disorder 0.000 0.145
PTSD-pulse post-N/L post-sleep disorder 0.000 0.202
Total indirect
effect
PTSD Leukocyte post 0.012 0.000*
PTSD-systolic BP post-leukocyte post 0.000 0.277
PTSD-diastolic BP post-leukocyte post 0.003 0.047*
PTSD-pulse post-leukocyte post 0.010 0.003*
Total indirect
effect
PTSD N/L post 0.047 0.000*
PTSD-systolic blood pressure-N/L post 0.002 0.326
PTSD-diastolic blood pressure-N/L post 0.026 0.000*
PTSD-pulse post-N/L post 0.019 0.003*
Total indirect PTSD Platelet post 0.000 0.853
PTSD-Systolic BP-Platelet post 0.000 0.479
PTSD-Diastolic BP-platelet post -0.002 0.003*
PTSD-pulse post-platelet post 0.001 0.009*
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Table 3
Direct effects for male study participants
Predictors Outcomes β P-value
Systolic BP pre Leukocyte Pre 0.220 0.082
Diastolic BP pre -0.148 0.126
Pulse Pre 0.509 0.001*
Systolic BP pre Platelet Pre 0.074 0.003*
Diastolic BP pre 0.003 0.889
Pulse Pre 0.046 0.019*
Systolic BP pre N/L ratio Pre -0.122 0.556
Diastolic BP pre -0.096 0.644
Pulse Pre 0.506 0.010*
Leukocyte Pre PTSD 0.042 0.658
Platelet Pre 0.592 0.064
N/L ratio Pre 0.148 0.396
PTSD Systolic BP Post -0.044 0.000*
PTSD Diastolic BP Post -0.006 0.555
PTSD Pulse Post 0.060 0.000*
Systolic BP post Leukocyte Post -0.091 0.060
Diastolic BP post -0.077 0.121
Pulse post 0.207 0.000*
PTSD 0.005 0.180
Systolic BP post Platelet Post 0.057 0.000*
Diastolic BP post 0.006 0.544
Pulse post 0.016 0.170
PTSD 0.005 0.180
Systolic BP post N/L ratio -0.998 0.000*
Diastolic BP post 0.253 0.242
Pulse post 0.875 0.002*
PTSD -0.211 0.026*
Leukocyte post CVD -0.011 0.728
Platelet post -0.468 0.000*
N/L ratio post 0.146 0.000*
PTSD 0.109 0.000*
Systolic BP post -0.019 0.785
Diastolic BP post -0.154 0.005*
Pulse post -0.269 0.003*
Leukocyte post Sleep disorder -0.014 0.603
Platelet post -0.116 0.375
N/L ratio post 0.043 0.060
PTSD 0.133 0.000*
Systolic BP post -0.044 0.385
Diastolic BP Post -0.022 0.509
Pulse post -0.130 0.068
CVD WITH Sleep 0.007 0.000*
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Table 4
Indirect effects for male study participants
Predictor Outcome β p-value
Total indirect
effect
Systolic BP CVD -0.171 0.000*
Specific effect Systolic BP post-leukocyte post-CVD 0.001 0.732
Systolic BP post-platelet post-CVD -0.027 0.002*
Systolic BP post-N/L post-CVD -0.146 0.000*
Total indirect
effect
Diastolic BP post CVD 0.035 0.257
Specific effect Diastolic BP post-leukocyte post-CVD 0.001 0.735
Diastolic BP post-platelet post-CVD -0.003 0.547
Diastolic BP post-N/L post-CVD 0.037 0.217
Total indirect
effect
Pulse post CVD 0.118 0.009*
Specific effect Pulse post-leukocyte post-CVD -0.002 0.728
Pulse post-platelet post-CVD -0.008 0.146
Pulse post-N/L post-CVD 0.128 0.003*
Total indirect
effect
PTSD CVD -0.034 0.022*
Specific effect PTSD-systolic BP post-CVD 0.001 0.538
PTSD-diastolic BP post-CVD 0.001 0.786
PTSD-pulse post-CVD -0.016 0.008*
PTSD-leukocyte post-CVD 0.000 0.732
PTSD-platelet post-CVD -0.003 0.219
PTSD-N/L post-CVD -0.031 0.018*
PTSD-systolic BP post-leukocyte post-CVD 0.000 0.769
PTSD-diastolic BP post-leukocyte post-CVD 0.000 0.733
PTSD-pulse post-leukocyte post-CVD 0.000 0.728
PTSD-systolic BP post-platelet post-CVD 0.000 0.662
PTSD-diastolic BP post-platelet post-CVD 0.001 0.008*
PTSD-pulse post-platelet post-CVD 0.000 0.157
PTSD-systolic BP post_N/L post-CVD 0.000 0.596
PTSD-diastolic BP post-N/L post-CVD 0.006 0.001*
PTSD-pulse post-N/L post-CVD 0.008 0.009*
Total indirect
effect
Systolic BP post Sleep disorder -0.048 0.023*
Specific effect Systolic BP post-leukocyte post-sleep disorder -0.042 0.051
Systolic BP post-platelet post-sleep disorder 0.001 0.624
Systolic BP post-N/L post-sleep disorder -0.007 0.368
Total indirect
effect
Diastolic BP post Sleep disorder 0.011 0.223
Specific effect Diastolic BP post-leukocyte post-sleep disorder 0.001 0.621
Diastolic BP post-platelet post-sleep disorder -0.001 0.623
Diastolic BP post-N/L post-sleep disorder 0.011 0.206
Total indirect
effect
Pulse post Sleep disorder 0.033 0.171
Specific effect Pulse post-leukocyte post-sleep disorder -0.003 0.605
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Pulse post-platelet post-sleep disorder -0.002 0.416
Pulse post-N/L post-sleep disorder 0.037 0.119
Total indirect
effect
PTSD Sleep disorder -0.012 0.120
Specific effect PTSD-systolic BP post-sleep disorder 0.000 0.660
PTSD-diastolic BP post-sleep disorder 0.002 0.389
PTSD-pulse post-sleep disorder -0.008 0.072
PTSD-leukocyte post-sleep disorder 0.000 0.620
PTSD-platelet post-sleep disorder -0.001 0.484
PTSD-N/L post-sleep disorder -0.009 0.122
PTSD-systolic BP post_leukocyte post-sleep
disorder
0.000 0.707
PTSD-diastolic BP post_leukocyte post-sleep
disorder
0.000 0.625
PTSD-pulse post-leukocyte post-sleep disorder 0.000 0.606
PTSD-systolic BP post-platelet post-sleep disorder 0.000 0.697
PTSD-diastolic BP post-platelet post-sleep disorder 0.000 0.375
PTSD- pulse post-platelet post-sleep disorder 0.000 0.420
PTSD-systolic BP post-N/L post-sleep disorder 0.000 0.596
PTSD-diastolic BP post-N/L post-sleep disorder 0.002 0.066
PTSD-pulse post-N/L post-sleep disorder 0.002 0.133
Total indirect
effect
PTSD Leukocyte post 0.017 0.000*
Specific effect PTSD-systolic BP post-leukocyte post 0.000 0.585
PTSD-diastolic BP post-leukocyte post 0.004 0.076
PTSD-pulse post-leukocyte post 0.012 0.003*
Total indirect
effect
PTSD N/L post 0.094 0.000*
Specific effect PTSD-systolic BP post-N/L post -0.002 0.600
PTSD-diastolic BP post-N/L post 0.044 0.001*
PTSD-pulse post-N/L post 0.052 0.006*
Total indirect
effect
PTSD Platelet post -0.002 0.113
Specific effect PTSD-systolic BP post-platelet post 0.000 0.660
PTSD-diastolic BP post-platelet post -0.002 0.001*
PTSD-pulse post-platelet post 0.001 0.181
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Table 5
Direct effects for female study participants
Predictors Outcomes β p-value
Systolic BP pre Leukocyte Pre -0.159 0.077
Diastolic BP pre -0.103 0.282
Pulse Pre 0.223 0.046*
Systolic BP pre Platelet Pre 0.033 0.226
Diastolic BP pre 0.025 0.399
Pulse Pre 0.004 0.894
Systolic BP pre N/L ratio Pre -1.154 0.130
Diastolic BP pre -0.318 0.181
Pulse Pre 0.468 0.242
Leukocyte Pre PTSD -0.233 0.173
Platelet Pre 0.810 0.154
N/L ratio Pre 0.122 0.058
PTSD Systolic BP Post -0.052 0.000*
PTSD Diastolic BP Post -0.004 0.652
PTSD Pulse Post 0.020 0.105
Systolic BP post Leukocyte Post -0.106 0.096
Diastolic BP post -0.029 0.510
Pulse post 0.524 0.001*
PTSD -0.029 0.159
Systolic BP post Platelet Post 0.045 0.152
Diastolic BP post 0.021 0.324
Pulse post 0.101 0.008*
PTSD 0.014 0.003*
Systolic BP post N/L ratio -0.428 0.043*
Diastolic BP post 0.063 0.590
Pulse post 0.468 0.002*
PTSD -0.145 0.008*
Leukocyte post CVD -0.001 0.932
Platelet post -0.060 0.377
N/L ratio post 0.002 0.541
PTSD 0.127 0.000*
Systolic BP post 0.040 0.116
Diastolic BP post -0.007 0.688
Pulse post -0.020 0.201
Leukocyte post Sleep disorder 0.005 0.607
Platelet post -0.066 0.149
N/L ratio post 0.009 0.107
PTSD 0.127 0.000*
Systolic BP post -0.035 0.167
Diastolic BP post 0.091 0.000*
Pulse post -0.026 0.164
CVD WITH Sleep 0.019 0.000*
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Table 6
Indirect effects for female study participants
Predictor Outcome β P-value
Total indirect
effect
Systolic BP post CVD -0.003 0.400
Specific indirect Systolic BP post-leukocyte post-CVD -0.001 0.551
Systolic BP post-platelet post-CVD 0.000 0.932
Systolic BP post-N/L post-CVD -0.003 0.431
Total indirect
effect
Diastolic BP post CVD -0.001 0.569
Specific indirect Diastolic BP post-leukocyte post-CVD 0.000 0.934
Diastolic BP post-platelet post-CVD -0.001 0.509
Diastolic BP post-N/L post-CVD 0.000 0.737
Total indirect
effect
Pulse CVD -0.006 0.464
Specific indirect Pulse-leukocyte post-CVD 0.000 0.932
Pulse post-platelet post-CVD -0.006 0.295
Pulse post-N/L post-CVD 0.001 0.548
Total indirect
effect
PTSD CVD -0.003 0.048*
Specific indirect PTSD-systolic BP post-CVD 0.000 0.757
PTSD-diastolic BP post-CVD -0.002 0.122
PTSD-pulse post-CVD 0.000 0.387
PTSD-leukocyte post-CVD 0.000 0.933
PTSD-platelet post-CVD -0.001 0.365
PTSD-N/L post-CVD 0.000 0.544
PTSD-systolic BP post-leukocyte post-CVD 0.000 0.935
PTSD-diastolic BP post-leukocyte post-CVD 0.000 0.932
PTSD-pulse post-leukocyte post-CVD 0.000 0.932
PTSD-systolic BP post-platelet post-CVD 0.000 0.738
PTSD-diastolic BP post-platelet post-CVD 0.000 0.435
PTSD-pulse post-platelet post-CVD 0.000 0.360
PTSD-systolic BP post-N/L post-CVD 0.000 0.786
PTSD-diastolic BP post-N/L post-CVD 0.000 0.552
PTSD-pulse post-N/L post-CVD 0.000 0.576
Total indirect
effect
Systolic BP post Sleep
disorder
-0.007 0.064
Specific indirect Systolic BP post-leukocyte post-sleep
disorder
-0.001 0.613
Systolic BP post-platelet post-sleep disorder -0.003 0.234
Systolic BP post-N/L post-sleep disorder -0.004 0.143
Total indirect
effect
Diastolic BP post Sleep
disorder
-0.001 0.641
Specific indirect Diastolic BP post-leukocyte post-sleep
disorder
0.000 0.678
Diastolic BP post-platelet post-sleep disorder 0.001 0.601






Specific indirect Pulse post-leukocyte post-sleep disorder 0.003 0.617
Pulse post-platelet post-sleep disorder -0.007 0.167
Pulse post-N/L post-sleep disorder 0.004 0.153
Total indirect PTSD Sleep -0.001 0.603
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effect disorder
Specific indirect PTSD-systolic BP post-sleep disorder 0.000 0.643
PTSD-diastolic bp post-sleep disorder 0.002 0.177
PTSD-pulse post-sleep disorder -0.001 0.337
PTSD-leukocyte post-sleep disorder 0.000 0.645
PTSD-platelet post-sleep disorder -0.001 0.205
PTSD-N/L post-sleep disorder -0.001 0.085
PTSD-systolic BP post-leukocyte post-sleep
disorder
0.000 0.765






PTSD-systolic Bp post-platelet post-sleep
disorder
0.000 0.731
PTSD-diastolic BP post-platelet post-sleep
disorder
0.000 0.244
PTSD-pulse post-platelet post-sleep disorder 0.000 0.298
PTSD-systolic BP post-N/L post-sleep
disorder
0.000 0.729
PTSD-diastolic BP post-N/L post-sleep
disorder
0.000 0.154






Specific indirect PTSD-systolic BP post-leukocyte post 0.000 0.724
PTSD-diastolic BP post-leukocyte post 0.006 0.105
PTSD-pulse post-leukocyte post 0.011 0.144
Total indirect
effect
PTSD N/L post 0.032 0.030*
Specific indirect PTSD-systolic BP post-N/L post 0.000 0.725
PTSD-diastolic BP post-N/L post 0.022 0.051
PTSD-pulse post-N/L post 0.010 0.157
Total indirect
effect
PTSD Platelet post 0.000 0.853
Specific indirect PTSD-systolic BP post-platelet post 0.000 0.718
PTSD-diastolic BP post-platelet post -0.002 0.162
PTSD-pulse post-platelet post 0.002 0.156
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Table 7
Direct effects for white study participants
Predictors Outcomes β p-value
Systolic BP Pre Leukocyte Pre 0.046 0.628
Diastolic BP Pre -0.140 0.085
Pulse BP Pre 0.345 0.006*
Systolic BP Pre Platelet Pre 0.051 0.018*
Diastolic BP Pre -0.014 0.467
Pulse BP Pre 0.027 0.226
Systolic BP Pre N/L ratio Pre -0.873 0.123
Diastolic BP Pre -0.401 0.050
Pulse BP Pre 0.376 0.214
Leukocyte Pre PTSD 0.222 0.025*
Platelet Pre -0.548 0.245
N/L ratio Pre -0.135 0.147
PTSD Systolic BP Post -0.039 0.000*
PTSD Diastolic BP Post 0.010 0.109
PTSD Pulse Post 0.028 0.004*
Systolic BP post Leukocyte Post -0.082 0.062
Diastolic BP post -0.069 0.068
Pulse post 0.307 0.001*
PTSD 0.009 0.600
Systolic BP post Platelet post 0.044 0.002*
Diastolic BP post 0.017 0.087
Pulse post 0.040 0.006*
PTSD -0.003 0.351
Systolic BP post N/L ratio post -0.725 0.000*
Diastolic BP post 0.122 0.442
Pulse post 0.659 0.001*
PTSD -0.117 0.050
Leukocyte post CVD 0.015 0.297
Platelet post -0.465 0.000*
N/L ratio post 0.041 0.005*
PTSD 0.088 0.000*
Systolic BP post -0.017 0.621
Diastolic BP post -0.079 0.005*
Pulse post -0.090 0.015*
Leukocyte post Sleep disorder -0.001 0.963
Platelet post -0.141 0.020*
N/L ratio post 0.016 0.112
PTSD 0.125 0.000*
Systolic BP post -0.052 0.071
Diastolic BP post 0.040 0.177
Pulse post -0.030 0.244
CVD WITH Sleep 0.011 0.000*
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Table 8
Indirect effects for white study participants
Predictor Outcome β P-value
Total indirect effect Systolic BP post CVD -0.051 0.000*
Specific effect Systolic BP post-leukocyte post-CVD -0.001 0.362
Systolic BP post-platelet post-CVD -0.020 0.006*
Systolic BP post-N/L post-CVD -0.029 0.008*
Total indirect effect Diastolic BP post CVD -0.004 0.649
Specific effect Diastolic BP post-leukocyte post-CVD -0.001 0.352
Diastolic BP post-platelet post-CVD -0.008 0.088
Diastolic BP post-N/L post-CVD 0.005 0.466
Total indirect effect Pulse post CVD 0.013 0.362
Specific effect Pulse post-leukocyte post-CVD 0.005 0.311
Pulse post-platelet post-CVD -0.019 0.006*
Pulse post-N/L post-CVD 0.027 0.014*
Total indirect effect PTSD CVD -0.004 0.326
Specific effect PTSD-systolic BP post-CVD -0.001 0.139
PTSD-diastolic BP post-CVD 0.001 0.622
PTSD-pulse-CVD -0.003 0.096
PTSD-leukocyte post-CVD 0.000 0.650
PTSD-platelet post-CVD 0.001 0.352
PTSD-N/L post-CVD -0.005 0.063
PTSD-systolic BP post-leukocyte post-
CVD
0.000 0.401
PTSD-diastolic BP post-leukocyte post-
CVD
0.000 0.367
PTSD-pulse post-leukocyte post-CVD 0.000 0.332
PTSD-systolic BP post-platelet post-
CVD
0.00 0.202
PTSD-diastolic BP post-platelet post-
CVD
0.001 0.011*
PTSD-pulse post-platelet post-CVD -0.001 0.031*
PTSD-systolic BP post-N/L post-CVD 0.000 0.511
PTSD-diastolic BP post-N/L post-CVD 0.001 0.015*
PTSD-pulse post-N/L post-CVD 0.001 0.056
Total indirect effect Systolic BP post Sleep
disorder
-0.017 0.022*
Specific effect Systolic BP-leukocyte post-sleep disorder 0.000 0.963
Systolic Bp post-platelet post-sleep
disorder
-0.006 0.046*
Systolic BP post-N/L post-sleep disorder -0.011 0.096
Total indirect effect Diastolic BP post Sleep
disorder
0.000 0.898
Specific effect Diastolic BP post-leukocyte post-sleep
disorder
0.000 0.963
Diastolic BP post-platelet post-sleep
disorder
-0.002 0.179
Diastolic BP post-N/L post-sleep disorder 0.002 0.429
Total indirect effect Pulse post Sleep
disorder
0.004 0.606
Specific effect Pulse post-leukocyte post-sleep disorder 0.000 0.963
Pulse post-platelet post-sleep disorder -0.006 0.056
Pulse post-N/L post-sleep disorder 0.010 0.142
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Total indirect effect PTSD Sleep
disorder
0.000 0.621
Specific effect PTSD-systolic BP post-Sleep disorder 0.000 0.347
PTSD-diastolic BP post-Sleep disorder 0.002 0.078
PTSD-pulse-Sleep disorder -0.001 0.285
PTSD-leukocyte post-Sleep disorder 0.000 0.964
PTSD-platelet post-Sleep disorder 0.000 0.372
PTSD-N/L post-Sleep disorder -0.002 0.123
PTSD-systolic BP post-leukocyte post-
Sleep disorder
0.000 0.963






PTSD-systolic BP post-platelet post-
Sleep disorder
0.000 0.272






PTSD-systolic BP post-N/L post-Sleep
disorder
0.000 0.482
PTSD-diastolic BP post-N/L post-Sleep
disorder
0.000 0.110
PTSD-pulse post-N/L post-Sleep disorder 0.000 0.188
Total indirect effect PTSD Leukocyte
post
0.011 0.006*
Specific effect PTSD-systolic BP post-leukocyte -0.001 0.188
PTSD-diastolic BP post-leukocyte post 0.003 0.075
PTSD- pulse post-leukocyte post 0.009 0.020*
Total indirect effect PTSD N/L post 0.105 0.383
Specific effect PTSD-systolic BP post-N/L post 0.099 0.261
PTSD-diastolic BP post-N/L post 0.024 0.689
PTSD-pulse post-N/L post -0.018 0.761
Total indirect effect PTSD Platelet post 0.000 0.638
Specific effect PTSD-systolic BP post-platelet post 0.000 0.203
PTSD-diastolic BP post-platelet post -0.002 0.005*
PTSD-pulse post-platelet post 0.001 0.031*
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Table 9
Direct effects for non-white study participants
Predictors Outcomes β p-value
Systolic BP Pre Leukocyte Pre -0.145 0.301
Diastolic BP Pre 0.060 0.674
Pulse BP Pre 0.279 0.076
Systolic BP Pre Platelet Pre 0.086 0.119
Diastolic BP Pre 0.048 0.269
Pulse BP Pre 0.056 0.352
Systolic BP Pre N/L ratio Pre -0.436 0.012*
Diastolic BP Pre -0.080 0.597
Pulse BP Pre 0.362 0.048*
Leukocyte Pre PTSD 0.379 0.000*
Platelet Pre -0.172 0.539
N/L ratio Pre -0.214 0.003*
PTSD Systolic BP Post -0.029 0.017*
PTSD Diastolic BP Post -0.008 0.677
PTSD Pulse Post 0.028 0.075
Systolic BP post Leukocyte Post -0.100 0.380
Diastolic BP post -0.001 0.993
Pulse post 0.413 0.000*
PTSD -0.040 0.126
Systolic BP post Platelet post 0.097 0.233
Diastolic BP post -0.076 0.343
Pulse post 0.139 0.074
PTSD 0.003 0.608
Systolic BP post N/L ratio post -1.015 0.023*
Diastolic BP post 0.740 0.046*
Pulse post 0.510 0.001*
PTSD -0.080 0.281
Leukocyte post CVD -0.015 0.324
Platelet post -0.014 0.911
N/L ratio post 0.015 0.191
PTSD 0.065 0.000*
Systolic BP post 0.079 0.067
Diastolic BP post 0.010 0.741
Pulse post -0.043 0.095
Leukocyte post Sleep disorder 0.022 0.331
Platelet post 0.040 0.705
N/L ratio post -0.008 0.214
PTSD 0.130 0.000*
Systolic BP post -0.045 0.397
Diastolic BP post 0.058 0.124
Pulse post -0.117 0.025*
CVD WITH Sleep 0.012 0.002*
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Table 10
Indirect effects for non-white study participants
Predictor Outcome β P-value
Total indirect effect Systolic BP post CVD -0.015 0.461
Specific indirect Systolic BP post-leukocyte post-CVD 0.001 0.533
Systolic BP post-platelet post-CVD -0.001 0.905
Systolic BP post-N/L post-CVD -0.015 0.366
Total indirect effect Diastolic BP post CVD 0.012 0.438
Specific indirect Diastolic BP post-leukocyte post-CVD 0.000 0.993
Diastolic BP post-platelet post-CVD 0.001 0.903
Diastolic BP post-N/L post-CVD 0.011 0.395
Total indirect effect Pulse post CVD 0.000 0.982
Specific indirect Pulse post-leukocyte post-CVD -0.006 0.325
Pulse-platelet post-CVD -0.002 0.907
Pulse post-N/L post-CVD 0.008 0.308
Total indirect effect PTSD CVD -0.004 0.089
Specific indirect PTSD-systolic BP post-CVD 0.000 0.739
PTSD-diastolic BP post-CVD -0.002 0.138
PTSD-pulse post-CVD -0.001 0.241
PTSD-leukocyte post-CVD 0.001 0.400
PTSD-platelet post-CVD 0.000 0.913
PTSD-N/L post-CVD -0.001 0.255
PTSD-systolic BP post-leukocyte post-CVD 0.000 0.993
PTSD-diastolic BP post-leukocyte post-CVD 0.000 0.555
PTSD-pulse post-leukocyte post-CVD 0.000 0.386
PTSD-systolic BP post-platelet post-CVD 0.000 0.905
PTSD-diastolic BP post-platelet post-CVD 0.000 0.906
PTSD-pulse post-platelet post-CVD 0.000 0.906
PTSD-systolic BP post-N/L post-CVD 0.000 0.706
PTSD-diastolic post-N/L post-CVD 0.000 0.397
PTSD-pulse post-N/L post-CVD 0.000 0.381
Total indirect effect Systolic BP post Sleep
disorder
0.010 0.517
Specific indirect Systolic BP post-leukocyte post-sleep disorder -0.002 0.518
Systolic BP post-platelet-sleep disorder 0.004 0.749
Systolic BP post-N/L post-sleep disorder 0.008 0.354
Total indirect effect Diastolic BP post Sleep
disorder
-0.009 0.479
Specific indirect Diastolic BP post-leukocyte post-sleep disorder 0.000 0.993
Diastolic BP post-platelet post-sleep disorder -0.003 0.761
Diastolic BP post-N/L post-sleep disorder -0.006 0.387
Total indirect effect Pulse post Sleep
disorder
0.010 0.638
Specific indirect Pulse post-leukocyte post-sleep disorder 0.009 0.356
Pulse post-platelet post-sleep disorder 0.006 0.738
Pulse post-N/L post-sleep disorder -0.004 0.277
Total indirect effect PTSD Sleep
disorder
-0.002 0.469
Specific indirect PTSD-systolic BP post-sleep disorder 0.000 0.647
PTSD-diastolic BP post-sleep disorder 0.001 0.436
PTSD-pulse post-sleep disorder -0.003 0.175
PTSD-leukocyte post-sleep disorder -0.001 0.429
PTSD-platelet post-sleep disorder 0.000 0.753
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PTSD-N/L post-sleep disorder 0.001 0.295
PTSD-systolic BP post-leukocyte post-sleep
disorder
0.000 0.993
PTSD-diastolic BP post-leukocyte post-sleep
disorder
0.000 0.535
PTSD-pulse post-leukocyte post-sleep disorder 0.000 0.424
PTSD-systolic BP post-platelet post-sleep
disorder
0.000 0.816
PTSD-diastolic BP post-platelet post-sleep
disorder
0.000 0.748
PTSD-pulse post-platelet post-sleep disorder 0.000 0.747
PTSD-systolic BP post-N/L post-sleep disorder 0.000 0.704
PTSD-diastolic post-N/L post-sleep disorder 0.000 0.393
PTSD-pulse post-N/L post-sleep disorder 0.000 0.353
Total indirect effect PTSD Leukocyte
post
0.014 0.047*
Specific indirect PTSD-systolic BP post-leukocyte post 0.000 0.993
PTSD-diastolic BP post-leukocyte count 0.003 0.420
PTSD-pulse post-leukocyte post 0.011 0.106
Total indirect effect PTSD N/L post 0.038 0.089
Specific indirect PTSD-systolic BP post-N/L post -0.006 0.683
PTSD-diastolic BP post-N/L post 0.029 0.098
PTSD-pulse post-N/L post 0.014 0.117
Total indirect effect PTSD Platelet post 0.002 0.606
Specific indirect PTSD-systolic BP post-platelet post 0.001 0.720
PTSD-diastolic BP post-platelet post -0.003 0.265
PTSD-pulse post-platelet post 0.004 0.242
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Table 11
Direct effects for age group 0-17 (children)
Predictor Outcome β p-value
Systolic BP pre Leukocyte pre -1.155 0.000*
Diastolic BP pre 0.412 0.248
Pulse BP pre -0.477 0.088
Systolic BP pre Platelet pre 0.007 0.945
Diastolic BP pre 0.139 0.316
Pulse BP pre -0.114 0.015*
Systolic BP pre N/L pre -0.208 0.388
Diastolic BP pre 0.380 0.283
Pulse BP pre 0.052 0.750
Leukocyte pre PTSD -0.035 0.213
Platelet pre 0.257 0.071
N/L pre -0.011 0.485
PTSD Systolic BP pre -0.040 0.001*
Diastolic BP pre 0.030 0.002*
Pulse BP pre -0.171 0.000*
Systolic BP post Leukocyte post -0.390 0.055
Diastolic BP post 0.103 0.700
Pulse BP post 0.277 0.137
PTSD -0.041 0.329
Systolic BP post Platelet post -0.079 0.209
Diastolic BP post 0.070 0.168
Pulse BP post 0.045 0.225
PTSD -0.010 0.316
Systolic BP post N/L post -0.035 0.678
Diastolic BP post -0.044 0.699
Pulse BP post 0.172 0.100
PTSD 0.005 0.933
Leukocyte post CVD 0.000 0.451
Platelet post 0.000 0.515
N/L post 0.000 0.353
PTSD 0.000 0.328
Systolic BP post 0.000 0.510
Diastolic BP post -0.001 0.328
Pulse post 0.000 0.506
Leukocyte post Sleep disorder 0.004 0.284
Platelet post 0.012 0.407
N/L post -0.001 0.060
PTSD 0.042 0.000*
Systolic BP post 0.008 0.117
Diastolic BP post -0.001 0.816
Pulse post -0.005 0.368
CVD WITH Sleep disorder 0.032 0.000*
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Table 12
Indirect effects for age group 0-17 years (children)
Predictor Outcome β p-value
Total indirect
effect
Systolic BP post CVD 0.000 0.478
Specific indirect
effect
Systolic Bp post-leukocyte post-CVD 0.000 0.714
Systolic BP post-Plat post-CVD 0.000 0.497
Systolic BP post-N/L-CVD 0.000 0.584
Total indirect
effects
Diastolic BP post CVD 0.000 0.593
Specific indirect
effect
Diastolic BP post-Leuko post-CVD 0.000 0.732
Diastolic BP post- Plat post-CVD 0.000 0.744
Diastolic BP Pot-N/L- CVD 0.000 0.566
Total indirect
effect
Pulse post CVD 0.000 0.502
Specific indirect
effect
Pulse post-leukocyte post-CVD 0.000 0.514
Pulse post-platelet post-CVD 0.000 0.563
Pulse post-N/L post-CVD 0.000 0.454
Total indirect
effect
PTSD CVD 0.000 0.467
Specific indirect
effect
PTSD-sys BP post-CVD 0.000 0.347
PTSD-diastolic BP post-CVD 0.000 0.493
PTSD-pulse post-CVD 0.000 0.505
PTSD-leukocyte post-CVD 0.000 0.555
PTSD-platelet post-PTSD 0.000 0.598
PTSD-N/L post-PTSD 0.000 0.935
PTSD-systolic BP post-leuko post-CVD 0.000 0.743
PTSD-diastolic BP post-leuko post-
CVD
0.000 0.504
PTSD-pulse post-leuko post-CVD 0.000 0.514
PTSD-systolic BP post-plat post-CVD 0.000 0.572
PTSD-diastolic BP post-plat post-CVD 0.000 0.586
PTSD-pulse post-plat post-CVD 0.000 0.564
PTSD-systolic BP post-N/L post-CVD 0.000 0.731
PTSD-diastolic BP post-N/L post-CVD 0.000 0.717
PTSD-pulse post-N/L post-CVD 0.000 0.453
Total indirect
effect





Systolic BP post-leuko post-sleep
disorder
-0.002 0.378
Systolic BP post-plat post-sleep disorder -0.001 0.520
Ssytolic BP post-N/L post-sleep disorder 0.000 0.696
Total indirect
effect
Diastolic BP post Sleep
disorder
0.001 0.538
Diastolic BP post-leuko post-sleep
disorder
0.000 0.731
Diastolic BP post-plat post-sleep
disorder
0.001 0.494










Pulse post-leuko post-sleep disorder 0.001 0.408
Pulse post-plat post-sleep disorder 0.001 0.489








PTSD-sys BP post-sleep disorder 0.000 0.818
PTSD-diastolic BP post-sleep disorder 0.000 0.131
PTSD-pulse post-sleep disorder 0.001 0.367
PTSD-leukocyte post-sleep disorder 0.000 0.478
PTSD-platelet post-sleep disorder 0.000 0.543
PTSD-N/L post-sleep disorder 0.000 0.934
PTSD-systolic BP post-leuko post-sleep
disorder
0.000 0.731






PTSD-systolic BP post-plat post-sleep
disorder
0.000 0.502






PTSD-systolic BP post-N/L post-sleep
disorder
0.000 0.717













PTSD-systolic BP post-leukocyte post 0.003 0.700
PTSD-diastolic BP post-leukocyte post -0.016 0.092






PTSD-systolic BP post-platelet post 0.002 0.197
PTSD-diastolic BP post-platelet post -0.003 0.230
PTSD-pulse post-platelet post -0.008 0.229
Total indirect
effect
PTSD N/L post -0.032 0.090
Specific indirect
effect
PTSD-systolic BP post-N/L post -0.001 0.698
PTSD-diastolic BP post-N/L post -0.001 0.682
PTSD-pulse post-N/L post -0.029 0.098
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Table 13
Direct effects for age group 18-49 years (adult)
Predictor Outcome β p-value
Systolic BP pre Leukocyte pre -0.069 0.507
Diastolic BP pre -0.091 0.436
Pulse BP pre 0.310 0.004*
Systolic BP pre Platelet pre 0.066 0.005*
Diastolic BP pre 0.007 0.797
Pulse BP pre -0.007 0.758
Systolic BP pre N/L pre -1.502 0.187
Diastolic BP pre -0.550 0.015*
Pulse BP pre 0.791 0.077
Leukocyte pre PTSD 0.487 0.000*
Platelet pre -1.375 0.096
N/L pre -0.396 0.009*
PTSD Systolic BP pre -0.011 0.091
Diastolic BP pre 0.012 0.132
Pulse BP pre 0.026 0.025*
Systolic BP post Leukocyte post -0.027 0.632
Diastolic BP post -0.072 0.187
Pulse BP post 0.236 0.000*
PTSD -0.024 0.138
Systolic BP post Platelet post 0.034 0.043*
Diastolic BP post 0.007 0.649
Pulse BP post 0.029 0.006*
PTSD 0.002 0.649
Systolic BP post N/L post -0.249 0.017*
Diastolic BP post 0.007 0.161
Pulse BP post 0.223 0.002*
PTSD -0.043 0.238
Leukocyte post CVD -0.005 0.237
Platelet post -0.015 0.416
N/L post -0.001 0.257
PTSD 0.029 0.000*
Systolic BP post -0.011 0.281
Diastolic BP post -0.002 0.790
Pulse post 0.006 0.364
Leukocyte post Sleep disorder -0.010 0.197
Platelet post 0.014 0.731
N/L post 0.000 0.933
PTSD 0.107 0.000*
Systolic BP post -0.027 0.112
Diastolic BP post 0.013 0.338
Pulse post -0.020 0.108
CVD WITH Sleep disorder 0.005 0.000*
119
Table 14
Indirect effects for age group 18-49 years (adult)
Predictor Outcome β P-value
Total indirect
effect
Systolic BP post CVD 0.000 0.847
Specific indirect
effect
Systolic Bp post-leukocyte post-CVD 0.000 0.636
Systolic BP post-Plat post-CVD -0.001 0.445
Systolic BP post-N/L-CVD 0.000 0.312
Total indirect
effects
Diastolic BP post CVD 0.000 0.427
Specific indirect
effect
Diastolic BP post-Leuko post-CVD 0.000 0.692
Diastolic BP post- Plat post-CVD 0.000 0.334
Diastolic BP Pot-N/L- CVD 0.000 0.385
Total indirect
effect
Pulse post CVD -0.002 0.145
Specific indirect
effect
Pulse post-leukocyte post-CVD -0.001 0.252
Pulse post-platelet post-CVD 0.000 0.425
Pulse post-N/L post-CVD 0.000 0.284
Total indirect
effect
PTSD CVD 0.003 0.216
Specific indirect
effect
PTSD-sys BP post-CVD 0.000 0.793
PTSD-diastolic BP post-CVD 0.001 0.372
PTSD-pulse post-CVD 0.000 0.424
PTSD-leukocyte post-CVD 0.000 0.356
PTSD-platelet post-PTSD 0.000 0.697
PTSD-N/L post-PTSD 0.001 0.395
PTSD-systolic BP post-leuko post-CVD 0.000 0.480
PTSD-diastolic BP post-leuko post-
CVD
0.000 0.653
PTSD-pulse post-leuko post-CVD 0.000 0.313
PTSD-systolic BP post-plat post-CVD 0.000 0.703
PTSD-diastolic BP post-plat post-CVD 0.000 0.489
PTSD-pulse post-plat post-CVD 0.000 0.451
PTSD-systolic BP post-N/L post-CVD 0.000 0.419
PTSD-diastolic BP post-N/L post-CVD 0.000 0.396
PTSD-pulse post-N/L post-CVD 0.000 0.331
Total indirect
effect





Systolic BP post-leuko post-sleep
disorder
0.000 0.647
Systolic BP post-plat post-sleep disorder 0.000 0.742
Systolic BP post-N/L post-sleep disorder 0.000 0.933
Total indirect
effect
Diastolic BP post Sleep
disorder
0.001 0.312
Diastolic BP post-leuko post-sleep
disorder
0.001 0.364
Diastolic BP post-plat post-sleep
disorder
0.000 0.769










Pulse post-leuko post-sleep disorder -0.002 0.226
Pulse post-plat post-sleep disorder 0.000 0.738








PTSD-sys BP post-sleep disorder 0.000 0.450
PTSD-diastolic BP post-sleep disorder 0.000 0.235
PTSD-pulse post-sleep disorder -0.001 0.253
PTSD-leukocyte post-sleep disorder 0.000 0.314
PTSD-platelet post-sleep disorder 0.000 0.768
PTSD-N/L post-sleep disorder 0.000 0.933
PTSD-systolic BP post-leuko post-sleep
disorder
0.000 0.435






PTSD-systolic BP post-plat post-sleep
disorder
0.000 0.773






PTSD-systolic BP post-N/L post-sleep
disorder
0.000 0.934













PTSD-systolic BP post-leukocyte post -0.001 0.322
PTSD-diastolic BP post-leukocyte post 0.000 0.648






PTSD-systolic BP post-platelet post 0.000 0.664
PTSD-diastolic BP post-platelet post 0.000 0.193
PTSD-pulse post-platelet post 0.001 0.077
Total indirect
effect
PTSD N/L post 0.010 0.014*
Specific indirect
effect
PTSD-systolic BP post-N/L post 0.002 0.319
PTSD-diastolic BP post-N/L post 0.003 0.174
PTSD-pulse post-N/L post 0.006 0.082
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Table 15
Direct effects for age group older than 50 (older adult)
Predictor Outcome β p-value
Systolic BP pre Leukocyte pre 0.034 0.732
Diastolic BP pre -0.099 0.206
Pulse BP pre 0.199 0.291
Systolic BP pre Platelet pre 0.066 0.032*
Diastolic BP pre -0.030 0.232
Pulse BP pre 0.038 0.462
Systolic BP pre N/L pre -0.089 0.566
Diastolic BP pre 0.030 0.874
Pulse BP pre 0.378 0.084
Leukocyte pre PTSD -0.176 0.104
Platelet pre -0.648 0.156
N/L pre 0.515 0.000*
PTSD Systolic BP post -0.061 0.000*
Diastolic BP post 0.003 0.779
Pulse BP post 0.029 0.053
Systolic BP post Leukocyte post -0.114 0.051
Diastolic BP post -0.031 0.464
Pulse BP post 0.223 0.097
PTSD 0.026 0.236
Systolic BP post Platelet post -0.003 0.928
Diastolic BP post 0.028 0.119
Pulse BP post -0.080 0.049*
PTSD -0.011 0.038*
Systolic BP post N/L post -1.807 0.000*
Diastolic BP post 0.722 0.078
Pulse BP post -0.301 0.558
PTSD 0.056 0.683
Leukocyte post CVD 0.245 0.000*
Platelet post -1.471 0.000*
N/L post -0.189 0.000*
PTSD 0.194 0.000*
Systolic BP post -0.615 0.000*
Diastolic BP post 0.203 0.081
Pulse post -0.694 0.000*
Leukocyte post Sleep disorder 0.057 0.002*
Platelet post -0.406 0.000*
N/L post -0.018 0.012*
PTSD 0.138 0.000*
Systolic BP post -0.114 0.002*
Diastolic BP post 0.090 0.008*
Pulse post -0.108 0.001*
CVDWITH Sleep disorder 0.001 0.040
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Table 16
Indirect effects for age group older than 50 (older adult)
Predictor Outcome β p-value
Total indirect
effect
Systolic BP post CVD 0.318 0.000*
Specific indirect
effect
Systolic Bp post-leukocyte post-CVD -0.028 0.044*
Systolic BP post-Plat post-CVD 0.004 0.928
Systolic BP post-N/L-CVD 0.342 0.000*
Total indirect
effects
Diastolic BP post CVD 0.186 0.012*
Specific indirect
effect
Diastolic BP post-Leuko post-CVD -0.008 0.483
Diastolic BP post- Plat post-CVD -0.041 0.156
Diastolic BP Pot-N/L- CVD -0.136 0.051
Total indirect
effect
Pulse post CVD 0.228 0.004*
Specific indirect
effect
Pulse post-leukocyte post-CVD 0.054 0.180
Pulse post-platelet post-CVD 0.117 0.121
Pulse post-N/L post-CVD 0.057 0.571
Total indirect
effect
PTSD CVD 0.017 0.624
Specific indirect
effect
PTSD-sys BP post-CVD 0.001 0.781
PTSD-diastolic BP post-CVD 0.038 0.000*
PTSD-pulse post-CVD -0.020 0.056
PTSD-leukocyte post-CVD 0.006 0.241
PTSD-platelet post-PTSD 0.016 0.073
PTSD-N/L post-PTSD -0.011 0.687
PTSD-systolic BP post-leuko post-CVD 0.000 0.783
PTSD-diastolic BP post-leuko post-
CVD
0.002 0.052
PTSD-pulse post-leuko post-CVD 0.002 0.282
PTSD-systolic BP post-plat post-CVD 0.000 0.773
PTSD-diastolic BP post-plat post-CVD 0.000 0.928
PTSD-pulse post-plat post-CVD 0.003 0.202
PTSD-systolic BP post-N/L post-CVD 0.000 0.787
PTSD-diastolic BP post-N/L post-CVD -0.021 0.001*
PTSD-pulse post-N/L post-CVD 0.002 0.596
Total indirect
effect





Systolic BP post-leuko post-sleep
disorder
-0.006 0.062
Systolic BP post-plat post-sleep disorder 0.001 0.928
Systolic BP post-N/L post-sleep disorder 0.033 0.019*
Total indirect
effect
Diastolic BP post Sleep
disorder
-0.026 0.014*
Diastolic BP post-leuko post-sleep
disorder
-0.002 0.480














Pulse post-leuko post-sleep disorder 0.013 0.180
Pulse post-plat post-sleep disorder 0.032 0.087








PTSD-sys BP post-sleep disorder 0.000 0.785
PTSD-diastolic BP post-sleep disorder 0.007 0.005*
PTSD-pulse post-sleep disorder -0.003 0.071
PTSD-leukocyte post-sleep disorder 0.001 0.261
PTSD-platelet post-sleep disorder 0.005 0.060
PTSD-N/L post-sleep disorder -0.001 0.691
PTSD-systolic BP post-leuko post-sleep
disorder
0.000 0.783






PTSD-systolic BP post-plat post-sleep
disorder
0.000 0.772






PTSD-systolic BP post-N/L post-sleep
disorder
0.000 0.788













PTSD-systolic BP post-leukocyte post 0.000 0.782
PTSD-diastolic BP post-leukocyte post 0.007 0.060






PTSD-systolic BP post-platelet post 0.000 0.772
PTSD-diastolic BP post-platelet post 0.000 0.928
PTSD-pulse post-platelet post -0.002 0.143
Total indirect
effect
PTSD N/L post 0.104 0.013*
Specific indirect
effect
PTSD-systolic BP post-N/L post 0.002 0.787
PTSD-diastolic BP post-N/L post 0.111 0.003*
PTSD-pulse post-N/L post -0.009 0.586
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Table 17
Direct effects for lower BMI group
Predictor Outcome β p-value
Systolic BP pre Leukocyte pre -0.211 0.082
Diastolic BP pre -0.080 0.383
Pulse BP pre 0.167 0.380
Systolic BP pre Platelet pre 0.041 0.334
Diastolic BP pre 0.010 0.817
Pulse BP pre -0.007 0.884
Systolic BP pre N/L pre -2.324 0.057
Diastolic BP pre -0.794 0.180
Pulse BP pre 1.428 0.075
Leukocyte pre PTSD 0.084 0.494
Platelet pre -0.113 0.774
N/L pre -0.046 0.102
PTSD Systolic BP post -0.022 0.361
Diastolic BP post 0.049 0.100
Pulse BP post -0.003 0.937
Systolic BP post Leukocyte post -0.152 0.392
Diastolic BP post -0.196 0.270
Pulse BP post 0.374 0.021*
PTSD -0.007 0.907
Systolic BP post Platelet post 0.094 0.024*
Diastolic BP post -0.039 0.306
Pulse BP post 0.073 0.025*
PTSD 0.011 0.422
Systolic BP post N/L post -2.277 0.031*
Diastolic BP post 2.104 0.094
Pulse BP post 0.770 0.052
PTSD -0.010 0.968
Leukocyte post CVD 0.014 0.645
Platelet post -0.161 0.300
N/L post 0.040 0.001*
PTSD 0.055 0.081
Systolic BP post 0.158 0.045*
Diastolic BP post -0.011 0.895
Pulse post 0.000 1.000
Leukocyte post Sleep disorder -0.018 0.377
Platelet post -0.251 0.012*
N/L post 0.003 0.681
PTSD 0.109 0.000*
Systolic BP post 0.022 0.604
Diastolic BP post 0.006 0.888
Pulse post 0.019 0.447
CVD WITH Sleep disorder 0.009 0.175
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Table 18
Indirect effects for lower BMI group
Predictor Outcome β p-value
Total effect Systolic BP post CVD -0.107 0.079
Systolic BP post-leukocyte post-CVD -0.002 0.709
Systoli BP post-platelet post-CVD -0.015 0.383
Systolic BP post-N/L post-CVD -0.090 0.078
Diastolic BP post CVD 0.087 0.138
Diastolic BP post-leukocyte post-CVD -0.003 0.631
Diastolic BP post-platelet post-CVD 0.006 0.459
Diastolic BP post-N/L post-CVD 0.083 0.132
Pulse post CVD 0.024 0.348
Pulse post-leukocyte post-CVD 0.005 0.645
Pulse-platelet post-CVD -0.012 0.315
Pulse post-N/L post-CVD 0.030 0.096
Total indirect effect PTSD CVD 0.000 0.985
PTSD-systolic BP post-CVD -0.001 0.895
PTSD-diastolic BP post-CVD -0.004 0.433
PTSD-pulse post-CVD 0.000 1.000
PTSD-leukocyte post-CVD 0.000 0.904
PTSD-platelet post-CVD -0.002 0.442
PTSD-N/L post-CVD 0.000 0.968
PTSD-systolic BP post-leukocyte post-
CVD
0.000 0.628
PTSD-diastolic BP post-leukocyte post-
CVD
0.000 0.741
PTSD-pulse post-leukocyte post-CVD 0.000 0.938
PTSD-systolic BP post-platelet post-
CVD
0.000 0.509
PTSD-diastolic BP post-platelet post-
CVD
0.000 0.562
PTSD-pulse post-platelet post-CVD 0.000 0.937
PTSD-systolic BP post-N/L post-CVD 0.004 0.284
PTSD-diastolic post-N/L post-CVD 0.002 0.438
PTSD-pulse post-N/L post-CVD 0.000 0.937
Total indirect effect Systolic BP post Sleep
disorder
-0.027 0.270
Systolic BP post-leukocyte post-sleep
disorder
0.003 0.463
Systolic BP post-platelet-sleep disorder -0.024 0.134
Systolic BP post-N/L post-sleep disorder -0.006 0.674
Total indirect effect Diastolic BP post Sleep
disorder
0.019 0.341
Diastolic BP post-leukocyte post-sleep
disorder
0.003 0.535
Diastolic BP post-platelet post-sleep
disorder
0.010 0.387
Diastolic BP post-N/L post-sleep disorder 0.006 0.681
Total indirect effect Pulse post Sleep
disorder
-0.023 0.128
Pulse post-leukocyte post-sleep disorder -0.007 0.354
Pulse post-platelet post-sleep disorder -0.018 0.065
Pulse post-N/L post-sleep disorder 0.002 0.671
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Total indirect effect PTSD Sleep
disorder
-0.001 0.789
PTSD-systolic BP post-Sleep disorder 0.000 0.889
PTSD-diastolic BP post-Sleep disorder 0.000 0.657
PTSD-pulse post-Sleep disorder 0.000 0.938
PTSD-leukocyte post-Sleep disorder 0.000 0.907
PTSD-platelet post-Sleep disorder -0.003 0.448
PTSD-N/L post-Sleep disorder 0.000 0.967
PTSD-systolic BP post-leukocyte post-
Sleep disorder
0.000 0.549






PTSD-systolic BP post-platelet post-
Sleep disorder
0.000 0.468


















PTSD-systolic BP post-leukocyte post -0.010 0.320
PTSD-diastolic BP post-leukocyte count 0.003 0.567
PTSD-pulse post-leukocyte post -0.001 0.937
Total indirect
effects
PTSD N/L post 0.153 0.173
PTSD-systolic BP post-N/L post 0.104 0.270
PTSD-diastolic BP post-N/L post 0.051 0.412
PTSD-pulse post-N/L post -0.002 0.937
Total indirect effect PTSD Platelet post -0.004 0.332
PTSD-systolic BP post-platelet post -0.002 0.408
PTSD-diastolic BP post-platelet post -0.002 0.423
PTSD-pulse post-platelet post 0.000 0.938
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Table 19
Direct effects for higher BMI group
Predictor Outcome β P-value
Systolic BP pre Leukocyte pre 0.088 0.496
Diastolic BP pre -0.117 0.285
Pulse BP pre 0.271 0.020*
Systolic BP pre Platelet pre 0.069 0.005*
Diastolic BP pre -0.019 0.351
Pulse BP pre 0.000 0.990
Systolic BP pre N/L pre -0.275 0.179
Diastolic BP pre -0.383 0.055
Pulse BP pre -0.130 0.441
Leukocyte pre PTSD 0.054 0.447
Platelet pre -0.606 0.153
N/L pre -0.191 0.000*
PTSD Systolic BP post -0.031 0.036*
Diastolic BP post 0.025 0.089
Pulse BP post -0.009 0.760
Systolic BP post Leukocyte post 0.023 0.827
Diastolic BP post 0.004 0.973
Pulse BP post 0.023 0.881
PTSD 0.013 0.736
Systolic BP post Platelet post 0.085 0.002*
Diastolic BP post 0.004 0.481
Pulse BP post 0.023 0.881
PTSD 0.013 0.736
Systolic BP post N/L post -0.871 0.049*
Diastolic BP post -0.154 0.656
Pulse BP post 2.048 0.089
PTSD -0.175 0.109
Leukocyte post CVD -0.026 0.578
Platelet post -0.815 0.000*
N/L post 0.046 0.338
PTSD 0.021 0.354
Systolic BP post 0.059 0.492
Diastolic BP post -0.011 0.884
Pulse post -0.177 0.194
Leukocyte post Sleep disorder -0.012 0.687
Platelet post -0.396 0.006*
N/L post 0.028 0.388
PTSD 0.037 0.048*
Systolic BP post 0.004 0.947
Diastolic BP post 0.150 0.024*
Pulse post -0.096 0.296
CVD WITH Sleep disorder 0.008 0.002*
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Table 20
Indirect effects for higher BMI group
Predictor Outcome β P-value
Total effect Systolic BP post CVD -0.110 0.040*
Systolic BP post-leukocyte post-CVD -0.001 0.851
Systoli BP post-platelet post-CVD -0.069 0.019*
Systolic BP post-N/L post-CVD -0.040 0.358
Total indirect effect Diastolic BP post CVD -0.041 0.145
Diastolic BP post-leukocyte post-CVD 0.000 0.973
Diastolic BP post-platelet post-CVD -0.034 0.097
Diastolic BP post-N/L post-CVD -0.007 0.719
Total indirect effect Pulse post CVD 0.095 0.510
Pulse post-leukocyte post-CVD -0.001 0.875
Pulse-platelet post-CVD 0.001 0.942
Pulse post-N/L post-CVD 0.094 0.485
Total indirect effect PTSD CVD 0.002 0.892
PTSD-systolic BP post-CVD 0.000 0.884
PTSD-diastolic BP post-CVD -0.002 0.513
PTSD-pulse post-CVD 0.002 0.779
PTSD-leukocyte post-CVD 0.000 0.765
PTSD-platelet post-CVD 0.009 0.206
PTSD-N/L post-CVD -0.008 0.332
PTSD-systolic BP post-leukocyte post-
CVD
0.000 0.973
PTSD-diastolic BP post-leukocyte post-
CVD
0.000 0.852
PTSD-pulse post-leukocyte post-CVD 0.000 0.868
PTSD-systolic BP post-platelet post-CVD -0.001 0.238
PTSD-diastolic BP post-platelet post-
CVD
0.002 0.134
PTSD-pulse post-platelet post-CVD 0.000 0.946
PTSD-systolic BP post-N/L post-CVD 0.000 0.727
PTSD-diastolic post-N/L post-CVD 0.001 0.387
PTSD-pulse post-N/L post-CVD -0.001 0.809
Total indirect effect Systolic BP post Sleep
disorder
-0.058 0.101
Systolic BP post-leukocyte post-sleep
disorder
0.000 0.849
Systolic BP post-platelet-sleep disorder -0.034 0.036*
Systolic BP post-N/L post-sleep disorder -0.024 0.421
Total indirect effect Diastolic BP post Sleep
disorder
-0.021 0.205
Diastolic BP post-leukocyte post-sleep
disorder
0.000 0.974
Diastolic BP post-platelet post-sleep
disorder
-0.016 0.149
Diastolic BP post-N/L post-sleep disorder -0.004 0.727
Total indirect effect Pulse post Sleep
disorder
0.057 0.534
Pulse post-leukocyte post-sleep disorder 0.000 0.882
Pulse post-platelet post-sleep disorder 0.001 0.942
Pulse post-N/L post-sleep disorder 0.056 0.518
Total indirect effect PTSD Sleep 0.005 0.528
129
disorder
PTSD-systolic BP post-Sleep disorder 0.004 0.159
PTSD-diastolic BP post-Sleep disorder 0.000 0.947
PTSD-pulse post-Sleep disorder 0.001 0.786
PTSD-leukocyte post-Sleep disorder 0.000 0.806
PTSD-platelet post-Sleep disorder 0.004 0.222
PTSD-N/L post-Sleep disorder -0.005 0.377
PTSD-systolic BP post-leukocyte post-
Sleep disorder
0.000 0.974






PTSD-systolic BP post-platelet post-
Sleep disorder
0.000 0.279












PTSD-pulse post-N/L post-Sleep disorder 0.000 0.811
Total indirect effect PTSD Leukocyte
post
-0.001 0.880
PTSD-systolic BP post-leukocyte post 0.000 0.973
PTSD-diastolic BP post-leukocyte count -0.001 0.828
PTSD-pulse post-leukocyte post 0.000 0.870
Total indirect
effects
PTSD N/L post 0.005 0.939
PTSD-systolic BP post-N/L post -0.004 0.670
PTSD-diastolic BP post-N/L post 0.027 0.145
PTSD-pulse post-N/L post -0.018 0.774
Total indirect effect PTSD Platelet post -0.002 0.427
PTSD-systolic BP post-platelet post 0.001 0.223
PTSD-diastolic BP post-platelet post -0.003 0.098











Result for Full Model
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Figure 4
Path Model for Male Study Participants
Figure 5
Path Model for Female Study Participants
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Figure 6
Path model for white study participants
Figure 7
Path model for non-white study participants
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Figure 8
Path model for age group 0-17 years (children)
Figure 9
Path model for age group 18-49 years
136
Figure 10
Path model for age group 50 years and older (older adult)
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Figure 11
Path model for lower BMI group
Figure 12
Path model for higher BMI group
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